Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.516900090591262e-43,25.01487896957584,2439.0340756473565,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS4Y1', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.244899345023857e-40,0,0,68
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.993286928577952e-11,4.883518942825172,120.32331900081914,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",4.953318017516211e-09,0,0,37
3,Nonalcoholic fatty liver disease WP4396,1.33815859421832e-07,3.0324120009449564,47.993381790742625,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX5B', 'COX7A1', 'COX7C', 'BBC3', 'LEPR', 'MLX', 'UQCRFS1', 'CYC1', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.2168827377550165e-05,0,0,39
4,Cholesterol Biosynthesis Pathway WP197,2.3205439636478128e-07,17.56787548138639,268.3720312600813,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'CYP51A1', 'SC5D', 'MSMO1', 'HMGCR', 'DHCR7', 'LSS', 'FDFT1']",2.8832758748324072e-05,0,0,11
5,Oxidative phosphorylation WP623,7.344421525623856e-07,4.644212777332264,65.59557927165885,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF']",7.300354996470113e-05,0,0,21
6,Mitochondrial CIV Assembly WP4922,7.398548985024941e-06,5.9673311897106105,70.49940323103996,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",0.000612846474259566,0,0,14
7,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,3.903535356607523e-05,38.21880998080614,387.9607766738407,"['NSDHL', 'EBP', 'CYP51A1', 'SC5D', 'DHCR24', 'DHCR7']",0.0027715101031913414,0,0,6
8,"GPCRs, Class A Rhodopsin-like WP455",5.5539059576246434e-05,3.599492263056093,35.269351409090135,"['GPR27', 'P2RY12', 'GPR12', 'HTR1F', 'P2RY14', 'CHRM5', 'F2R', 'GPR85', 'OPRK1', 'ADRA1D', 'NMBR', 'HTR4', 'HTR5A', 'MCHR1', 'HCRTR2', 'HRH1', 'HTR7', 'MC1R']",0.0034503640761743095,0,0,18
9,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0002534873642886025,3.54997854997855,29.394520252832763,"['IDI1', 'HMGCS1', 'CYP51A1', 'MSMO1', 'DHCR24', 'HMGCR', 'LSS', 'SQLE', 'NSDHL', 'EBP', 'SCD', 'ACOT2', 'SC5D', 'DHCR7', 'FDFT1']",0.013998135561270603,0,0,15
10,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0005126523417903983,3.0982848445823334,23.472335312823958,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.0254788213869828,0,0,16
11,Mitochondrial complex III assembly WP4921,0.0020222610055769348,5.5732234314980795,34.573709380257355,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1']",0.09136942907015787,0,0,7
12,Selenium Micronutrient Network WP15,0.002681126704577006,3.061888246628131,18.131026858296003,"['SELENOM', 'GPX4', 'RFK', 'SELENOW', 'PNPO', 'PLAT', 'SELENOT', 'KMO', 'SELENOK', 'SEPHS2', 'LDLR', 'SELENOH']",0.11104333101456432,0,0,12
13,Cardiac Progenitor Differentiation WP2406,0.0031845677153063074,4.247277386290839,24.41946107778836,"['MESP1', 'TGFB1', 'TNNT2', 'NOG', 'KIT', 'ROR2', 'THY1', 'IGF1']",0.12174847342363346,0,0,8
14,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.0036336576317513862,7.954763427109975,44.68600705707284,"['SFRP1', 'SST', 'SMAD9', 'DCN', 'FOXO1']",0.12899484592717422,0,0,5
15,Senescence and Autophagy in Cancer WP615,0.004172620058450616,2.2541813630674707,12.351135611523086,"['GABARAPL1', 'JUN', 'CEBPB', 'TGFB1', 'CDKN1B', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'FN1', 'PLAT', 'IGF1', 'CXCL14', 'GABARAP', 'MAP1LC3A', 'IGFBP7', 'IL6ST', 'HRAS', 'SLC39A3']",0.13825281126999708,0,0,18
16,Monoamine GPCRs WP58,0.00477198704242773,4.457682458386683,23.826279263255216,"['HRH1', 'HTR7', 'HTR1F', 'CHRM5', 'ADRA1D', 'HTR4', 'HTR5A']",0.14822984750541135,0,0,7
17,Imatinib and Chronic Myeloid Leukemia WP3640,0.007121386729724866,4.773992322456814,23.605734538366157,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'KIT', 'PIM1']",0.20244911825150907,0,0,6
18,Proximal tubule transport WP4917,0.007332161224400731,3.185576923076923,15.658655454635348,"['ATP6V1G1', 'ABCB1', 'CA4', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.20244911825150907,0,0,9
19,ACE Inhibitor Pathway WP554,0.009046530460510514,19.0727969348659,89.74464221918356,"['TGFB1', 'ATP6AP2', 'AGT']",0.23663819151966978,0,0,3
20,TP53 network WP1742,0.010524502135531428,5.302109974424552,24.14606970626821,"['SUMO1', 'CDKN2A', 'GADD45A', 'BAX', 'BBC3']",0.26153387806795597,0,0,5
21,NRF2 pathway WP2884,0.012006495075518781,1.9807243380244115,8.759372133759861,"['HSP90AA1', 'TGFB1', 'SRXN1', 'HGF', 'SLC2A12', 'SLC39A11', 'SLC39A13', 'SLC7A11', 'SLC6A1', 'SLC5A3', 'SLC5A4', 'CES4A', 'DNAJB1', 'SLC39A6', 'SLC39A7', 'SLC39A3', 'FTL', 'CBR3']",0.28415371678727785,0,0,18
22,miR-509-3p alteration of YAP1/ECM axis WP3967,0.01517828233846027,6.359744408945687,26.63390789085742,"['COL5A1', 'PBX3', 'FN1', 'GPC6']",0.320563792653779,0,0,4
23,miRNA targets in ECM and membrane receptors WP2911,0.016047596380214045,4.544208987943003,18.777563106817674,"['COL5A1', 'COL5A3', 'ITGA1', 'COL5A2', 'FN1']",0.320563792653779,0,0,5
24,Statin inhibition of cholesterol production WP430,0.016047596380214045,4.544208987943003,18.777563106817674,"['SQLE', 'HMGCR', 'APOE', 'LDLR', 'FDFT1']",0.320563792653779,0,0,5
25,Composition of Lipid Particles WP3601,0.018520220694930728,inf,inf,"['APOE', 'LDLR']",0.320563792653779,0,0,2
26,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.018520220694930728,inf,inf,"['TGFB1', 'VIP']",0.320563792653779,0,0,2
27,COVID-19 adverse outcome pathway WP4891,0.018520220694930728,inf,inf,"['IL7', 'AGT']",0.320563792653779,0,0,2
28,Gastric acid production WP2596,0.018520220694930728,inf,inf,"['CCK', 'VIP']",0.320563792653779,0,0,2
29,Development of ureteric collection system WP5053,0.018704929551226542,2.829809950886184,11.259723742938139,"['GDF11', 'SALL1', 'FRAS1', 'ANOS1', 'ETV4', 'GLI3', 'FGFR2', 'FREM2']",0.320563792653779,0,0,8
30,Differentiation Pathway WP2848,0.020467003644704,3.4709474786250216,13.498310888365168,"['TGFB1', 'HGF', 'NOG', 'KIT', 'IGF1', 'FGF1']",0.3390700270472629,0,0,6
31,Vitamin D Receptor Pathway WP2877,0.028138527222609205,1.9398014818957081,6.92628536653752,"['ABCB1', 'TGFB1', 'CDKN1B', 'IGFBP5', 'GADD45A', 'CDKN2A', 'IGFBP3', 'FOXO1', 'PTHLH', 'ADAMTS5', 'SFRP1', 'PNOC', 'TIMP2', 'TIMP3']",0.45112412998828305,0,0,14
32,Peptide GPCRs WP24,0.03214331787101925,3.5336743393009376,12.14718467096983,"['MC1R', 'OPRK1', 'NMBR', 'ACKR1', 'HCRTR2']",0.49922590568426767,0,0,5
33,IL-18 signaling pathway WP4754,0.035796752871564134,1.505574912891986,5.013411029201014,"['CEBPB', 'TOMM40', 'STOML1', 'EPB41', 'CD81', 'RGS16', 'COX17', 'HSPB1', 'PLD1', 'CENPB', 'ADAMTS5', 'TMSB4X', 'TIMP3', 'CD36', 'JUN', 'TICAM2', 'USP5', 'PRKCD', 'FN1', 'NDUFC1', 'BPGM', 'RUNX2', 'ARL4D', 'SYT10', 'RFX5', 'CYCS', 'BAX', 'ITM2C', 'ARF6']",0.5049504050386059,0,0,29
34,Allograft Rejection WP2328,0.03612078000204261,2.620320855614973,8.701789349751518,"['ABCB1', 'TGFB1', 'COL5A1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F']",0.5049504050386059,0,0,7
35,Biogenic Amine Synthesis WP550,0.03657588446959721,6.35632183908046,21.029040011010732,"['GAD1', 'PAH', 'GAD2']",0.5049504050386059,0,0,3
36,Cellular Proteostasis WP4918,0.03657588446959721,6.35632183908046,21.029040011010732,"['VBP1', 'PFDN5', 'PFDN6']",0.5049504050386059,0,0,3
37,Nuclear Receptors Meta-Pathway WP2882,0.039975648235972404,1.4664643837595723,4.721259799648018,"['ABCB1', 'CDKN1B', 'SRXN1', 'SLC7A11', 'SLC6A1', 'SLC5A3', 'SLC5A4', 'FOXO1', 'DNAJB1', 'RGS2', 'SLC39A6', 'SLC39A7', 'CBR3', 'SLC39A3', 'JUN', 'HSP90AA1', 'TGFB1', 'HGF', 'SLC2A12', 'SLC39A11', 'AIP', 'SLC39A13', 'CES4A', 'TGFBR3', 'PSMC5', 'SCD', 'B3GNT5', 'BAX', 'MFGE8', 'FKBP5', 'FTL']",0.5369701938723861,0,0,31
38,Ferroptosis WP4313,0.04285256131368699,2.3143672471026733,7.290233364800742,"['PRNP', 'MAP1LC3A', 'GPX4', 'GSS', 'VDAC3', 'SAT2', 'SLC7A11', 'FTL']",0.5604663940237483,0,0,8
39,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.050524139876529456,12.707083599234206,37.934507999791336,"['BAX', 'IL6ST']",0.6101814891338542,0,0,2
40,miR-517 relationship with ARCN1 and USP1 WP3596,0.050524139876529456,12.707083599234206,37.934507999791336,"['ID2', 'ARCN1']",0.6101814891338542,0,0,2
41,Endochondral Ossification with Skeletal Dysplasias WP4808,0.05156463288455105,1.9894563822963438,5.898577526316371,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'IGF1', 'SOX6', 'GLI3', 'RUNX2', 'PTHLH']",0.6101814891338542,0,0,10
42,Endochondral Ossification WP474,0.05156463288455105,1.9894563822963438,5.898577526316371,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'IGF1', 'SOX6', 'GLI3', 'RUNX2', 'PTHLH']",0.6101814891338542,0,0,10
43,Zinc homeostasis WP3529,0.05569414613765491,2.8906068356196233,8.347726344399694,"['SLC39A6', 'SLC39A11', 'SLC39A13', 'SLC39A7', 'SLC39A3']",0.6209797776783199,0,0,5
44,Lung fibrosis WP3624,0.05584630202991902,2.544337811900192,7.340801245754498,"['CEBPB', 'TGFB1', 'HGF', 'FAM13A', 'IGF1', 'FGF1']",0.6209797776783199,0,0,6
45,Mevalonate pathway WP3963,0.057634080271837175,4.76676245210728,13.602629794793469,"['HMGCS1', 'HMGCR', 'ACAT2']",0.6209797776783199,0,0,3
46,Apoptosis Modulation and Signaling WP1772,0.06324718623636755,1.7769413451628804,4.905610214370004,"['HRK', 'JUN', 'ENDOG', 'BAG3', 'CDKN2A', 'PTRH2', 'HTRA2', 'CYCS', 'BAX', 'PRKD1', 'PTPN13', 'BBC3']",0.6209797776783199,0,0,12
47,Adipogenesis WP236,0.06474381744995239,1.6474171215550526,4.509503002245881,"['WWTR1', 'CEBPB', 'TGFB1', 'WNT5B', 'GADD45A', 'IGF1', 'FOXO1', 'AGT', 'LIPE', 'SFRP4', 'SCD', 'DDIT3', 'NDN', 'IL6ST', 'RXRG']",0.6209797776783199,0,0,15
48,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.0647909661769846,1.9750663129973476,5.4049449364037025,"['BEX3', 'CDKN1B', 'HSPA5', 'RIPK2', 'F2R', 'HSPB1', 'PTK2B', 'RNF7', 'APOE']",0.6209797776783199,0,0,9
49,Aryl Hydrocarbon Receptor Pathway WP2873,0.0682834674961288,2.3850767754318616,6.401754995274384,"['HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'AIP', 'BAX']",0.6209797776783199,0,0,6
50,Oxysterols derived from cholesterol WP4545,0.0682834674961288,2.3850767754318616,6.401754995274384,"['EBP', 'DBP', 'INSIG1', 'ACOT11', 'ACOT2', 'DHCR7']",0.6209797776783199,0,0,6
51,Photodynamic therapy-induced unfolded protein response WP3613,0.0682834674961288,2.3850767754318616,6.401754995274384,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'BBC3']",0.6209797776783199,0,0,6
52,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.06872009612134325,3.1785942492012778,8.511365058131087,"['CD81', 'HSPB1', 'IGF1', 'PDLIM5']",0.6209797776783199,0,0,4
53,Nanomaterial induced apoptosis WP2507,0.06872009612134325,3.1785942492012778,8.511365058131087,"['ENDOG', 'HTRA2', 'BAX', 'CYCS']",0.6209797776783199,0,0,4
54,Phytochemical activity on NRF2 transcriptional activation WP3,0.06872009612134325,3.1785942492012778,8.511365058131087,"['AIMP2', 'CEBPB', 'SLC7A11', 'EPHB2']",0.6209797776783199,0,0,4
55,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.06872009612134325,3.1785942492012778,8.511365058131087,"['DDR1', 'TGFB1', 'FN1', 'IGFBP7']",0.6209797776783199,0,0,4
56,7-oxo-C and 7beta-HC pathways WP5064,0.07037213502736771,2.6494565217391304,7.03154607569459,"['EBP', 'DBP', 'ACOT11', 'ACOT2', 'DHCR7']",0.6245526983678884,0,0,5
57,Matrix Metalloproteinases WP129,0.0831075858854334,3.8130268199233717,9.485359089824302,"['MMP16', 'TIMP2', 'TIMP3']",0.7246398278080771,0,0,3
58,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.08894819728630947,2.825133120340788,6.83597780841095,"['OMG', 'IGF1', 'ASCL1', 'SOX6']",0.7495884740718896,0,0,4
59,Cytokines and Inflammatory Response WP530,0.09200180466475909,6.352903637523931,15.157691922886237,"['TGFB1', 'IL7']",0.7495884740718896,0,0,2
60,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.09200180466475909,6.352903637523931,15.157691922886237,"['ID2', 'RUNX2']",0.7495884740718896,0,0,2
61,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.09200180466475909,6.352903637523931,15.157691922886237,"['APOE', 'LDLR']",0.7495884740718896,0,0,2
62,Pregnane X receptor pathway WP2876,0.11167016280568873,2.542364217252396,5.573385398725385,"['HSP90AA1', 'PSMC5', 'ABCB1', 'FOXO1']",0.8598436354105604,0,0,4
63,Alanine and aspartate metabolism WP106,0.11245439899735699,3.1772030651340994,6.942847908991521,"['GOT1', 'GAD1', 'GAD2']",0.8598436354105604,0,0,3
64,Development and heterogeneity of the ILC family WP3893,0.11245439899735699,3.1772030651340994,6.942847908991521,"['NFIL3', 'IL7', 'ID2']",0.8598436354105604,0,0,3
65,Genes targeted by miRNAs in adipocytes WP1992,0.11245439899735699,3.1772030651340994,6.942847908991521,"['TMSB4X', 'IGF1', 'KCNJ2']",0.8598436354105604,0,0,3
66,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.12555267325727634,2.1189258312020463,4.396834458240182,"['TGFBR3', 'TGFB1', 'HGF', 'MFGE8', 'HRAS']",0.8791781424764277,0,0,5
67,Folate Metabolism WP176,0.12555267325727634,2.1189258312020463,4.396834458240182,"['AHCY', 'GPX4', 'RFK', 'PLAT', 'LDLR']",0.8791781424764277,0,0,5
68,Spinal Cord Injury WP2431,0.13208088706012625,1.5551561831407787,3.148166054846557,"['TGFB1', 'CDKN1B', 'GADD45A', 'APEX1', 'CCNG1', 'OMG', 'XYLT1', 'AQP4', 'SLIT3', 'GFAP', 'TNFSF13B']",0.8791781424764277,0,0,11
69,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.13612675905278426,inf,inf,['FMO5'],0.8791781424764277,0,0,1
70,Codeine and Morphine Metabolism WP1604,0.13612675905278426,inf,inf,['ABCB1'],0.8791781424764277,0,0,1
71,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.13612675905278426,inf,inf,['AGT'],0.8791781424764277,0,0,1
72,Gastric Cancer Network 1 WP2361,0.1366576569159119,2.3110078419982574,4.599544218230287,"['SMOC2', 'ACTL6A', 'GATD3B', 'KIF15']",0.8791781424764277,0,0,4
73,One-carbon metabolism WP241,0.1366576569159119,2.3110078419982574,4.599544218230287,"['ALDH1L1', 'AHCY', 'CHDH', 'GLRX']",0.8791781424764277,0,0,4
74,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.1366576569159119,2.3110078419982574,4.599544218230287,"['HMGCS1', 'SCD', 'HMGCR', 'LDLR']",0.8791781424764277,0,0,4
75,Dopaminergic Neurogenesis WP2855,0.13978406345405134,4.234843650287173,8.332717427472028,"['TGFB1', 'ASCL1']",0.8791781424764277,0,0,2
76,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.13978406345405134,4.234843650287173,8.332717427472028,"['CEBPB', 'ALDH1L1']",0.8791781424764277,0,0,2
77,NAD Biosynthesis II (from tryptophan) WP2485,0.13978406345405134,4.234843650287173,8.332717427472028,"['NMNAT1', 'KMO']",0.8791781424764277,0,0,2
78,Computational Model of Aerobic Glycolysis WP4629,0.14505554865808265,2.7230432402846194,5.257212159690983,"['LDHA', 'PKM', 'PFKM']",0.8791781424764277,0,0,3
79,Cysteine and methionine catabolism WP4504,0.14505554865808265,2.7230432402846194,5.257212159690983,"['AHCY', 'GOT1', 'GSS']",0.8791781424764277,0,0,3
80,Glycolysis in senescence WP5049,0.14505554865808265,2.7230432402846194,5.257212159690983,"['LDHA', 'PKM', 'ALDOC']",0.8791781424764277,0,0,3
81,Kynurenine Pathway and links to Cellular Senescence WP5044,0.14505554865808265,2.7230432402846194,5.257212159690983,"['KMO', 'FOXO1', 'ACMSD']",0.8791781424764277,0,0,3
82,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.14505554865808265,2.7230432402846194,5.257212159690983,"['IDI1', 'HMGCS1', 'HMGCR']",0.8791781424764277,0,0,3
83,Glycolysis and Gluconeogenesis WP534,0.15178613923178824,1.8162873594735398,3.4242151871701805,"['LDHA', 'PKM', 'GOT1', 'PGAM1', 'ALDOC', 'PFKM']",0.9049038343377818,0,0,6
84,TGF-beta Receptor Signaling WP560,0.1529414931275124,1.7117354476509405,3.214125356631568,"['TGFBR3', 'JUN', 'TGFB1', 'NOG', 'SMAD9', 'HRAS', 'RUNX2']",0.9049038343377818,0,0,7
85,Methionine De Novo and Salvage Pathway WP3580,0.16364550229429786,2.1182108626198084,3.8340734225986277,"['AHCY', 'CHDH', 'ODC1', 'SRM']",0.9457187748868143,0,0,4
86,Nucleotide metabolism WP404,0.16364550229429786,2.1182108626198084,3.8340734225986277,"['PRPS1', 'NME2', 'OAZ1', 'SRM']",0.9457187748868143,0,0,4
87,Exercise-induced Circadian Regulation WP410,0.16899004360225223,1.5895259449071109,2.826042782343447,"['PER2', 'DNAJA1', 'IDI1', 'DAZAP2', 'CEBPB', 'SUMO1', 'RBPMS', 'HERPUD1']",0.9623187071589514,0,0,8
88,GABA receptor Signaling WP4159,0.17232669001437964,1.7335543535159659,3.0482182551808172,"['GABBR1', 'SLC32A1', 'GAD1', 'GAD2', 'SLC6A1', 'GABRD']",0.9623187071589514,0,0,6
89,"GPCRs, Other WP117",0.17232669001437964,1.7335543535159659,3.0482182551808172,"['HTR7', 'ADGRV1', 'HTR1F', 'F2R', 'ADRA1D', 'ACKR1']",0.9623187071589514,0,0,6
90,BMP Signaling Pathway in Eyelid Development WP3927,0.18026542115671929,2.3824233716475094,4.081865409369866,"['JUN', 'SFRP1', 'FGFR2']",0.9738251555966249,0,0,3
91,NOTCH1 regulation of endothelial cell calcification WP3413,0.18026542115671929,2.3824233716475094,4.081865409369866,"['ITGA1', 'PLAT', 'SOX6']",0.9738251555966249,0,0,3
92,TYROBP causal network in microglia WP3945,0.18026542115671929,2.3824233716475094,4.081865409369866,"['DPYD', 'LOXL3', 'LHFPL2']",0.9738251555966249,0,0,3
93,Modulators of TCR signaling and T cell activation WP5072,0.186571087736965,1.5412031914274067,2.587592225110485,"['FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'LCP2', 'RNF7', 'CD247', 'ZFP36L1']",0.9908325152592258,0,0,8
94,IL1 and megakaryocytes in obesity WP2865,0.1913881719615406,3.175813656668794,5.25105416987863,"['F2R', 'TIMP2']",0.9908325152592258,0,0,2
95,Sulfation Biotransformation Reaction WP692,0.1913881719615406,3.175813656668794,5.25105416987863,"['SULT4A1', 'PAPSS2']",0.9908325152592258,0,0,2
96,Transcriptional cascade regulating adipogenesis WP4211,0.1913881719615406,3.175813656668794,5.25105416987863,"['CEBPB', 'DDIT3']",0.9908325152592258,0,0,2
97,Pyrimidine metabolism WP4022,0.1939949006995825,1.3875634962340164,2.2754978538389903,"['NT5C', 'POLE4', 'NME6', 'POLE2', 'POLR1C', 'DPYD', 'POLE3', 'NME2', 'POLR2E', 'POLR2I', 'POLR2K', 'POLR2L']",0.9939738726566236,0,0,12
98,Airway smooth muscle cell contraction WP4962,0.2174472020416167,2.1174968071519795,3.2308749495072355,"['RYR1', 'PPP1R14A', 'MYLK']",0.9999313107513411,0,0,3
99,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.2174472020416167,2.1174968071519795,3.2308749495072355,"['TGFB1', 'FN1', 'RUNX2']",0.9999313107513411,0,0,3
100,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.2208228421777409,1.672163144433975,2.5256260466183145,"['LDHA', 'ANGPT2', 'PKM', 'IGFBP3', 'BAX']",0.9999313107513411,0,0,5
101,White fat cell differentiation WP4149,0.2224555668458087,1.8152441807393884,2.7283626433146413,"['CEBPB', 'DDIT3', 'NR2F2', 'FOXO1']",0.9999313107513411,0,0,4
102,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.23189616324858137,1.4829065300896287,2.1672168516540036,"['TGFBR3', 'JUN', 'TGFB1', 'NOG', 'SMAD9', 'HRAS', 'RUNX2']",0.9999313107513411,0,0,7
103,Oncostatin M Signaling Pathway WP2374,0.2339965877175113,1.3953095684803,2.0266156332087624,"['CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'TIMP3', 'PTK2B', 'IL6ST', 'HRAS', 'LDLR']",0.9999313107513411,0,0,9
104,Signaling of Hepatocyte Growth Factor Receptor WP313,0.23988202783301096,1.525067178502879,2.1771981460295007,"['JUN', 'HGF', 'ITGA1', 'GAB1', 'PTK2B', 'HRAS']",0.9999313107513411,0,0,6
105,Cancer immunotherapy by PD-1 blockade WP4585,0.24488981547258454,2.5403956604977664,3.5742018053124247,"['JUN', 'HLA-A']",0.9999313107513411,0,0,2
106,Dual hijack model of Vif in HIV infection WP3300,0.24488981547258454,2.5403956604977664,3.5742018053124247,"['ELOB', 'RUNX1']",0.9999313107513411,0,0,2
107,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.24488981547258454,2.5403956604977664,3.5742018053124247,"['GALNT3', 'FGFR2']",0.9999313107513411,0,0,2
108,Osteoclast Signaling WP12,0.24488981547258454,2.5403956604977664,3.5742018053124247,"['AIMP2', 'ATP6V1G1']",0.9999313107513411,0,0,2
109,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.24488981547258454,2.5403956604977664,3.5742018053124247,"['BUB3', 'ANAPC11']",0.9999313107513411,0,0,2
110,DNA Mismatch Repair WP531,0.2536744761347723,1.6940575079872204,2.323744484028546,"['POLE4', 'RPA3', 'POLE2', 'POLE3']",0.9999313107513411,0,0,4
111,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.2536744761347723,1.6940575079872204,2.323744484028546,"['NDUFA13', 'HSP90AA1', 'RIPK2', 'AAMP']",0.9999313107513411,0,0,4
112,Unfolded protein response WP4925,0.2536744761347723,1.6940575079872204,2.323744484028546,"['XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.9999313107513411,0,0,4
113,Drug Induction of Bile Acid Pathway WP2289,0.25373329771480907,6.349489795918367,8.708144755654235,['ABCB1'],0.9999313107513411,0,0,1
114,EV release from cardiac cells and their functional effects WP3297,0.25373329771480907,6.349489795918367,8.708144755654235,['RGS16'],0.9999313107513411,0,0,1
115,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.2559969047880962,1.9055555555555554,2.596490801998767,"['FGF9', 'FGFR2', 'GADD45G']",0.9999313107513411,0,0,3
116,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.2559969047880962,1.9055555555555554,2.596490801998767,"['BAX', 'PTHLH', 'BCL2L14']",0.9999313107513411,0,0,3
117,Nephrotic syndrome WP4758,0.26397805362640214,1.466263103499188,1.9529001524565759,"['MYO1E', 'ANLN', 'TRPC6', 'INF2', 'GPC5', 'WDR73']",0.9999313107513411,0,0,6
118,Base Excision Repair WP4752,0.2748398353711098,1.5126050420168067,1.9536304051035525,"['POLE4', 'NEIL2', 'APEX1', 'POLE2', 'POLE3']",0.9999313107513411,0,0,5
119,Complement system WP2806,0.2748398353711098,1.5126050420168067,1.9536304051035525,"['PRNP', 'RPS19', 'CD59', 'CALR', 'DCN']",0.9999313107513411,0,0,5
120,Genes controlling nephrogenesis WP4823,0.2857049248298246,1.5880191693290735,1.9894636378724444,"['CD36', 'ETV4', 'GLI3', 'FGFR2']",0.9999313107513411,0,0,4
121,Glycosylation and related congenital defects WP4521,0.2857049248298246,1.5880191693290735,1.9894636378724444,"['DPM3', 'MPI', 'MAGT1', 'MPDU1']",0.9999313107513411,0,0,4
122,NRF2-ARE regulation WP4357,0.2857049248298246,1.5880191693290735,1.9894636378724444,"['AIMP2', 'CEBPB', 'SLC7A11', 'EPHB2']",0.9999313107513411,0,0,4
123,One-carbon metabolism and related pathways WP3940,0.2886528428166855,1.4118148859031776,1.7542231250704299,"['GPX4', 'CHDH', 'GAD1', 'GSS', 'GAD2', 'PLD1']",0.9999313107513411,0,0,6
124,Vitamin B12 metabolism WP1533,0.2953587407695696,1.7321490769766632,2.112467680703633,"['PLAT', 'APOE', 'LDLR']",0.9999313107513411,0,0,3
125,Galanin receptor pathway WP4970,0.29881722273126055,2.116783663050415,2.556912069989123,"['CDKN1B', 'PRKCD']",0.9999313107513411,0,0,2
126,Glutathione metabolism WP100,0.29881722273126055,2.116783663050415,2.556912069989123,"['GPX4', 'GSS']",0.9999313107513411,0,0,2
127,Leptin and adiponectin WP3934,0.29881722273126055,2.116783663050415,2.556912069989123,"['LEPR', 'ADIPOR1']",0.9999313107513411,0,0,2
128,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.29881722273126055,2.116783663050415,2.556912069989123,"['SFRP1', 'TGFB1']",0.9999313107513411,0,0,2
129,Trans-sulfuration pathway WP2333,0.29881722273126055,2.116783663050415,2.556912069989123,"['AHCY', 'GOT1']",0.9999313107513411,0,0,2
130,Proteasome Degradation WP183,0.3104493732480939,1.2707692307692309,1.486462534552339,"['PSMD8', 'PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10']",0.9999313107513411,0,0,9
131,Genotoxicity pathway WP4286,0.3137789508511469,1.3612558267068824,1.5777860527527772,"['RPS27', 'GADD45A', 'BLOC1S2', 'ID2', 'PCDH8', 'PHLDA3']",0.9999313107513411,0,0,6
132,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.3182623330067707,1.4944559293365909,1.7109716428984876,"['RAB3B', 'RAB3A', 'HSPB1', 'RAB11A']",0.9999313107513411,0,0,4
133,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3212673830632567,1.3079197107780371,1.485118678933453,"['PPP1R14A', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'DDIT3']",0.9999313107513411,0,0,7
134,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.3332264681367796,1.2218137859574678,1.3426914106315166,"['IDI1', 'SQLE', 'HMGCS1', 'SCD', 'INSIG1', 'CYP51A1', 'HMGCR', 'LSS', 'LDLR', 'FDFT1']",0.9999313107513411,0,0,10
135,Constitutive Androstane Receptor Pathway WP2875,0.33503400534330535,1.5876436781609196,1.7361252649747976,"['HSP90AA1', 'ABCB1', 'FOXO1']",0.9999313107513411,0,0,3
136,Type II interferon signaling (IFNG) WP619,0.33503400534330535,1.5876436781609196,1.7361252649747976,"['PRKCD', 'HLA-B', 'IFIT2']",0.9999313107513411,0,0,3
137,Biomarkers for pyrimidine metabolism disorders WP4584,0.3520637338680186,1.814203664873735,1.8939253211058649,"['NT5C', 'DPYD']",0.9999313107513411,0,0,2
138,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.3520637338680186,1.814203664873735,1.8939253211058649,"['TULP3', 'SOX4']",0.9999313107513411,0,0,2
139,Major receptors targeted by epinephrine and norepinephrine WP4589,0.3520637338680186,1.814203664873735,1.8939253211058649,"['ADCY10', 'ADRA1D']",0.9999313107513411,0,0,2
140,Pyrimidine metabolism and related diseases WP4225,0.3520637338680186,1.814203664873735,1.8939253211058649,"['NT5C', 'DPYD']",0.9999313107513411,0,0,2
141,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.35533785357312747,3.174426020408163,3.284534929182986,['GSS'],0.9999313107513411,0,0,1
142,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.35533785357312747,3.174426020408163,3.284534929182986,['ABCB1'],0.9999313107513411,0,0,1
143,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.35533785357312747,3.174426020408163,3.284534929182986,['CD247'],0.9999313107513411,0,0,1
144,Platelet-mediated interactions with vascular and circulating cells WP4462,0.35533785357312747,3.174426020408163,3.284534929182986,['TGFB1'],0.9999313107513411,0,0,1
145,Tgif disruption of Shh signaling WP3674,0.35533785357312747,3.174426020408163,3.284534929182986,['GLI3'],0.9999313107513411,0,0,1
146,Vitamin B6-dependent and responsive disorders WP4228,0.35533785357312747,3.174426020408163,3.284534929182986,['PNPO'],0.9999313107513411,0,0,1
147,miRNA regulation of DNA damage response WP1530,0.36800401895823737,1.2350085360648742,1.2345903866162138,"['CDKN1B', 'GADD45A', 'CCNG1', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999313107513411,0,0,7
148,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.37458518871612717,1.4653698791629826,1.4388994797009256,"['FGF1', 'RUNX2', 'FGFR2']",0.9999313107513411,0,0,3
149,Ovarian infertility WP34,0.37458518871612717,1.4653698791629826,1.4388994797009256,"['CEBPB', 'CDKN1B', 'INHA']",0.9999313107513411,0,0,3
150,Pre-implantation embryo WP3527,0.37458518871612717,1.4653698791629826,1.4388994797009256,"['DLX2', 'DDIT3', 'ATP1A1']",0.9999313107513411,0,0,3
151,Proteoglycan biosynthesis WP4784,0.37458518871612717,1.4653698791629826,1.4388994797009256,"['XYLT1', 'B4GALT7', 'PAPSS2']",0.9999313107513411,0,0,3
152,Neovascularisation processes WP4331,0.3839082693367364,1.3368757356650411,1.2798601738264703,"['TGFB1', 'KIT', 'SMAD9', 'EPHB2']",0.9999313107513411,0,0,4
153,Copper homeostasis WP3286,0.38841729627336613,1.270076726342711,1.201079822716043,"['PRNP', 'JUN', 'COX17', 'FOXO1', 'ATOX1']",0.9999313107513411,0,0,5
154,Parkinson's disease pathway WP2371,0.38841729627336613,1.270076726342711,1.201079822716043,"['PINK1', 'HTRA2', 'CYCS', 'UBE2L6', 'PARK7']",0.9999313107513411,0,0,5
155,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.3915608716225855,1.2015088071426099,1.1265518302205735,"['SFRP4', 'SFRP1', 'JUN', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.9999313107513411,0,0,7
156,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.4038157645201087,1.5872686662412252,1.4393297241999838,"['NOG', 'RUNX2']",0.9999313107513411,0,0,2
157,Differentiation of white and brown adipocyte WP2895,0.4038157645201087,1.5872686662412252,1.4393297241999838,"['CEBPB', 'SMAD9']",0.9999313107513411,0,0,2
158,Fatty acid transporters WP5061,0.4038157645201087,1.5872686662412252,1.4393297241999838,"['FABP3', 'CD36']",0.9999313107513411,0,0,2
159,"GPCRs, Class B Secretin-like WP334",0.4038157645201087,1.5872686662412252,1.4393297241999838,"['VIPR2', 'ADGRG2']",0.9999313107513411,0,0,2
160,Mammalian disorder of sexual development WP4842,0.4038157645201087,1.5872686662412252,1.4393297241999838,"['FGF9', 'FGFR2']",0.9999313107513411,0,0,2
161,Breast cancer pathway WP4262,0.404384274423421,1.1158115055929967,1.0102442206337063,"['JUN', 'SHC3', 'WNT5B', 'GADD45A', 'TCF7', 'IGF1', 'FGF1', 'GADD45G', 'SFRP4', 'FGF9', 'KIT', 'BAX', 'HRAS']",0.9999313107513411,0,0,13
162,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.413636644013861,1.3605637657361795,1.2010612863117585,"['TICAM2', 'PLAT', 'TIRAP']",0.9999313107513411,0,0,3
163,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.413636644013861,1.3605637657361795,1.2010612863117585,"['TGFBR3', 'ANGPT2', 'RUNX2']",0.9999313107513411,0,0,3
164,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.413636644013861,1.3605637657361795,1.2010612863117585,"['HTR7', 'RPS6KA5', 'HTR4']",0.9999313107513411,0,0,3
165,Sleep regulation WP3591,0.413636644013861,1.3605637657361795,1.2010612863117585,"['AHCY', 'CRH', 'HCRTR2']",0.9999313107513411,0,0,3
166,Glucocorticoid Receptor Pathway WP2880,0.4163379261671168,1.1906190019193859,1.0432894562913173,"['TGFBR3', 'RGS2', 'HSP90AA1', 'JUN', 'B3GNT5', 'MFGE8']",0.9999313107513411,0,0,6
167,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4169817620149742,1.2211046626008262,1.0681158715745362,"['JUN', 'RIPK2', 'HSPB1', 'CYCS', 'ACTG1']",0.9999313107513411,0,0,5
168,p38 MAPK Signaling Pathway WP400,0.4169817620149742,1.2211046626008262,1.0681158715745362,"['RPS6KA5', 'DDIT3', 'HSPB1', 'HRAS', 'HMGN1']",0.9999313107513411,0,0,5
169,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.424858280846482,1.0586900129701686,0.9062382514455226,"['CDKN1B', 'COL11A1', 'HIF3A', 'FGF1', 'FOXO1', 'LIPE', 'RELN', 'FGF9', 'GNG4', 'PDGFC', 'HRAS', 'HSP90AA1', 'ANGPT2', 'HGF', 'F2R', 'FN1', 'VEGFB', 'PPP2R5B', 'IGF1', 'EFNA3', 'COL5A1', 'PIK3IP1', 'COL5A3', 'DDIT4', 'KIT', 'COL5A2', 'FGFR2']",0.9999313107513411,0,0,27
170,Osteoblast differentiation WP4787,0.42942950696764864,1.1140744741906081,0.9417245674441891,"['PRKCH', 'FGF9', 'WNT5B', 'PRKCD', 'SMAD9', 'PRKD1', 'FGF1', 'RUNX2', 'FGFR2', 'GLI3']",0.9999313107513411,0,0,10
171,Synaptic Vesicle Pathway WP2267,0.4386183932039613,1.1396631537476607,0.9392254751985092,"['RAB3A', 'SLC32A1', 'SLC1A3', 'SLC17A7', 'PARK7', 'SYN3', 'CPLX3']",0.9999313107513411,0,0,7
172,Eukaryotic Transcription Initiation WP405,0.44191819715451713,1.1544233118129472,0.9427372728813315,"['GTF2A2', 'TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'POLR2K']",0.9999313107513411,0,0,6
173,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.4431165001327365,2.1160714285714284,1.7223182817481928,['APOE'],0.9999313107513411,0,0,1
174,Bile acids synthesis and enterohepatic circulation  WP4389,0.4431165001327365,2.1160714285714284,1.7223182817481928,['LDLR'],0.9999313107513411,0,0,1
175,Blood Clotting Cascade WP272,0.4431165001327365,2.1160714285714284,1.7223182817481928,['PLAT'],0.9999313107513411,0,0,1
176,FOXP3 in COVID-19 WP5063,0.4431165001327365,2.1160714285714284,1.7223182817481928,['IL6ST'],0.9999313107513411,0,0,1
177,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.4431165001327365,2.1160714285714284,1.7223182817481928,['FN1'],0.9999313107513411,0,0,1
178,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4431165001327365,2.1160714285714284,1.7223182817481928,['VEGFB'],0.9999313107513411,0,0,1
179,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.4431165001327365,2.1160714285714284,1.7223182817481928,['STRADB'],0.9999313107513411,0,0,1
180,Nanoparticle triggered regulated necrosis WP2513,0.4431165001327365,2.1160714285714284,1.7223182817481928,['FTL'],0.9999313107513411,0,0,1
181,Role of Osx and miRNAs in tooth development WP3971,0.4431165001327365,2.1160714285714284,1.7223182817481928,['RUNX2'],0.9999313107513411,0,0,1
182,Somatic sex determination WP4814,0.4431165001327365,2.1160714285714284,1.7223182817481928,['FGF9'],0.9999313107513411,0,0,1
183,Aryl Hydrocarbon Receptor Netpath WP2586,0.4453157718113571,1.1757601591361182,0.9511566346314627,"['HSP90AA1', 'CDKN1B', 'AIP', 'CD36', 'HRAS']",0.9999313107513411,0,0,5
184,Bladder cancer WP2828,0.4487300164984776,1.2093108169785487,0.9690617189987574,"['RPS6KA5', 'CDKN2A', 'DAPK2', 'HRAS']",0.9999313107513411,0,0,4
185,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.45187284443679154,1.2697318007662834,1.008617114301465,"['B3GALNT1', 'B3GALT2', 'B3GALT1']",0.9999313107513411,0,0,3
186,Cell Differentiation - Index expanded WP2023,0.45349359850034027,1.4107636673048287,1.1155954050068317,"['ID2', 'RUNX2']",0.9999313107513411,0,0,2
187,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.45349359850034027,1.4107636673048287,1.1155954050068317,"['RYR1', 'CCK']",0.9999313107513411,0,0,2
188,Cori Cycle WP1946,0.45349359850034027,1.4107636673048287,1.1155954050068317,"['LDHA', 'PGAM1']",0.9999313107513411,0,0,2
189,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.45349359850034027,1.4107636673048287,1.1155954050068317,"['IL6ST', 'SOX4']",0.9999313107513411,0,0,2
190,Overview of nanoparticle effects WP3287,0.45349359850034027,1.4107636673048287,1.1155954050068317,"['FN1', 'BAX']",0.9999313107513411,0,0,2
191,Tryptophan catabolism leading to NAD+ production WP4210,0.45349359850034027,1.4107636673048287,1.1155954050068317,"['NMNAT1', 'KMO']",0.9999313107513411,0,0,2
192,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.47875071083938386,1.0805948178336309,0.795939402099607,"['PSMD8', 'TUBB2B', 'PSMC5', 'TUBB2A', 'HSPA5', 'TUBB', 'UBE2L6', 'HSPA1B']",0.9999313107513411,0,0,8
193,Androgen receptor signaling pathway WP138,0.4814694612589131,1.0580872913992299,0.7733691997926911,"['JUN', 'SUMO1', 'KAT5', 'BAG1', 'RNF6', 'PARK7', 'CALR', 'FKBP4', 'ETV5', 'RUNX2', 'FOXO1']",0.9999313107513411,0,0,11
194,Angiogenesis WP1539,0.4890350212033109,1.1902538314176245,0.8514137681298176,"['TIMP2', 'TIMP3', 'FGFR2']",0.9999313107513411,0,0,3
195,IL-7 signaling pathway WP205,0.4890350212033109,1.1902538314176245,0.8514137681298176,"['CDKN1B', 'IL7', 'PTK2B']",0.9999313107513411,0,0,3
196,DNA damage response WP707,0.492296418574213,1.0882369070468878,0.7712054925644485,"['CDKN1B', 'GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999313107513411,0,0,6
197,p53 transcriptional gene network WP4963,0.492296418574213,1.0882369070468878,0.7712054925644485,"['GADD45A', 'CCNG1', 'BAX', 'SLC7A11', 'BBC3', 'RPRM']",0.9999313107513411,0,0,6
198,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5001091095708994,1.057975656630365,0.733101998141082,"['JUN', 'TGFB1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999313107513411,0,0,8
199,ERK Pathway in Huntington's Disease WP3853,0.5007028540704033,1.2695596681557115,0.8782083273344505,"['RPS6KA5', 'HRAS']",0.9999313107513411,0,0,2
200,GDNF/RET signaling axis WP4830,0.5007028540704033,1.2695596681557115,0.8782083273344505,"['SALL1', 'GLI3']",0.9999313107513411,0,0,2
201,Type II diabetes mellitus WP1584,0.5007028540704033,1.2695596681557115,0.8782083273344505,"['SURF1', 'PRKCD']",0.9999313107513411,0,0,2
202,Urea cycle and metabolism of amino groups WP497,0.5007028540704033,1.2695596681557115,0.8782083273344505,"['ODC1', 'SRM']",0.9999313107513411,0,0,2
203,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5079929034486245,1.0068195711730477,0.6819066134547266,"['SET', 'TRAF3IP2', 'EPB41', 'HSPB1', 'RPL10A', 'APOLD1', 'FOXO1', 'RPL7', 'HERPUD1', 'ACTG1', 'SCUBE2', 'LDHA', 'RPS6KA5', 'RPL18A', 'TMSB4X', 'DNAJB4', 'RPLP2', 'DNAJB9', 'PTK2B', 'IGFBP7', 'MYH11', 'EPHB2', 'CCT7', 'IER5', 'HRAS', 'TXNDC5', 'JUN', 'HSP90AA1', 'SSR4', 'TRPC3', 'IGFBP3', 'PRKCD', 'FN1', 'GAB1', 'RPL13A', 'RAB11A', 'DNAJA1', 'RCN1', 'PTPN9', 'CYCS', 'RPL27', 'PRKD1', 'RPL26', 'CALR', 'EIF3D', 'ARF6']",0.9999313107513411,0,0,46
204,Myometrial relaxation and contraction pathways WP289,0.509174996579762,1.0237887657242497,0.6910200658181382,"['RYR1', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP3', 'RGS16', 'PRKCD', 'ACTG1', 'RGS2', 'PRKAR1A', 'GNG4', 'CRH', 'PRKD1', 'ATF5', 'CORIN']",0.9999313107513411,0,0,15
205,BDNF-TrkB Signaling WP3676,0.5112228741551255,1.103931101541881,0.7406821651406674,"['TRPC6', 'TRPC3', 'GAB1', 'HRAS']",0.9999313107513411,0,0,4
206,Phosphodiesterases in neuronal function WP4222,0.5169220087977737,1.0579014715291106,0.6980703235395912,"['ADCY10', 'PDE10A', 'PDE1A', 'PDE3A', 'PDE5A', 'PDE6B']",0.9999313107513411,0,0,6
207,Farnesoid X receptor pathway WP2879,0.5189495660826356,1.5868941326530612,1.040920946125897,['FKBP5'],0.9999313107513411,0,0,1
208,Inflammatory Response Pathway WP453,0.5189495660826356,1.5868941326530612,1.040920946125897,['FN1'],0.9999313107513411,0,0,1
209,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.5189495660826356,1.5868941326530612,1.040920946125897,['ACOT2'],0.9999313107513411,0,0,1
210,Liver X receptor pathway WP2874,0.5189495660826356,1.5868941326530612,1.040920946125897,['SCD'],0.9999313107513411,0,0,1
211,Mitochondrial fatty acid synthesis pathway WP4317,0.5189495660826356,1.5868941326530612,1.040920946125897,['HSD17B12'],0.9999313107513411,0,0,1
212,Peroxiredoxin 2 induced ovarian failure WP4873,0.5189495660826356,1.5868941326530612,1.040920946125897,['BAX'],0.9999313107513411,0,0,1
213,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.5189495660826356,1.5868941326530612,1.040920946125897,['FOXO1'],0.9999313107513411,0,0,1
214,Vitamin D Metabolism WP1531,0.5189495660826356,1.5868941326530612,1.040920946125897,['DHCR7'],0.9999313107513411,0,0,1
215,ESC Pluripotency Pathways WP3931,0.5247544767579758,1.0237124707732417,0.6601151780625805,"['JUN', 'FGF9', 'WNT5B', 'NOG', 'GAB1', 'SMAD9', 'FGF1', 'IL6ST', 'HRAS', 'FGFR2']",0.9999313107513411,0,0,10
216,Cell migration and invasion through p75NTR WP4561,0.5249167836523356,1.120126211404102,0.7219387458477734,"['JUN', 'EFNA3', 'EFNB3']",0.9999313107513411,0,0,3
217,Physiological and pathological hypertrophy of the heart WP1528,0.5249167836523356,1.120126211404102,0.7219387458477734,"['JUN', 'IL6ST', 'AGT']",0.9999313107513411,0,0,3
218,Apoptosis WP254,0.5303613408203018,1.0332310990679807,0.6552717839565506,"['HRK', 'JUN', 'CDKN2A', 'CYCS', 'BAX', 'IGF1', 'BBC3']",0.9999313107513411,0,0,7
219,Endometrial cancer WP4155,0.5303613408203018,1.0332310990679807,0.6552717839565506,"['GADD45A', 'TCF7', 'BAX', 'FGF1', 'HRAS', 'FGFR2', 'GADD45G']",0.9999313107513411,0,0,7
220,DNA Replication WP466,0.541231374867884,1.0578274760383386,0.649409185547851,"['DBF4', 'RPA3', 'POLE2', 'GMNN']",0.9999313107513411,0,0,4
221,Tumor suppressor activity of SMARCB1 WP4204,0.541231374867884,1.0578274760383386,0.649409185547851,"['H3F3B', 'CDKN2A', 'ACTL6A', 'GLI3']",0.9999313107513411,0,0,4
222,T-cell receptor (TCR) signaling pathway WP69,0.5419645913691779,1.0154516335682255,0.6220195786164394,"['JUN', 'TGFB1', 'RIPK2', 'PRKCD', 'PTK2B', 'LCP2', 'CD247', 'HRAS']",0.9999313107513411,0,0,8
223,Kallmann's Syndrome WP5074,0.5451948182198799,1.154029123397343,0.7000480110451195,"['ANOS1', 'ASCL1']",0.9999313107513411,0,0,2
224,Omega-9 FA synthesis WP4724,0.5451948182198799,1.154029123397343,0.7000480110451195,"['SCD', 'ACOT2']",0.9999313107513411,0,0,2
225,IL-6 signaling pathway WP364,0.5539842448384811,1.0236366636416137,0.6045792949482509,"['PRKCD', 'GAB1', 'VIP', 'IL6ST', 'AGT']",0.9999313107513411,0,0,5
226,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5646776863806822,1.0020204061016265,0.5726548396416182,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'HRAS', 'RXRG']",0.9999313107513411,0,0,6
227,PPAR signaling pathway WP3942,0.5795090917452403,0.9915481138107417,0.5409627986355955,"['FABP3', 'SCD', 'SLC27A6', 'CD36', 'RXRG']",0.9999313107513411,0,0,5
228,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5844617979717147,1.2693877551020407,0.6817422859167139,['TCF7'],0.9999313107513411,0,0,1
229,Biomarkers for urea cycle disorders WP4583,0.5844617979717147,1.2693877551020407,0.6817422859167139,['GOT1'],0.9999313107513411,0,0,1
230,Caloric restriction and aging WP4191,0.5844617979717147,1.2693877551020407,0.6817422859167139,['IGF1'],0.9999313107513411,0,0,1
231,"Degradation pathway of sphingolipids, including diseases WP4153",0.5844617979717147,1.2693877551020407,0.6817422859167139,['NEU1'],0.9999313107513411,0,0,1
232,Disorders of Folate Metabolism and Transport WP4259,0.5844617979717147,1.2693877551020407,0.6817422859167139,['ALDH1L1'],0.9999313107513411,0,0,1
233,Eicosanoid Synthesis WP167,0.5844617979717147,1.2693877551020407,0.6817422859167139,['PTGES2'],0.9999313107513411,0,0,1
234,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5844617979717147,1.2693877551020407,0.6817422859167139,['AHCY'],0.9999313107513411,0,0,1
235,Methylation Pathways WP704,0.5844617979717147,1.2693877551020407,0.6817422859167139,['NNMT'],0.9999313107513411,0,0,1
236,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5844617979717147,1.2693877551020407,0.6817422859167139,['TGFB1'],0.9999313107513411,0,0,1
237,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.5844617979717147,1.2693877551020407,0.6817422859167139,['JUN'],0.9999313107513411,0,0,1
238,Complement and Coagulation Cascades WP558,0.5868341354670087,1.0577536694320357,0.5637965223666689,"['F2R', 'PLAT']",0.9999313107513411,0,0,2
239,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5868341354670087,1.0577536694320357,0.5637965223666689,"['BAX', 'BBC3']",0.9999313107513411,0,0,2
240,Purinergic signaling WP4900,0.5868341354670087,1.0577536694320357,0.5637965223666689,"['P2RY12', 'P2RY14']",0.9999313107513411,0,0,2
241,Transcription co-factors SKI and SKIL protein partners WP4533,0.5868341354670087,1.0577536694320357,0.5637965223666689,"['SATB2', 'MERTK']",0.9999313107513411,0,0,2
242,Transcription factor regulation in adipogenesis WP3599,0.5868341354670087,1.0577536694320357,0.5637965223666689,"['CEBPB', 'FOXO1']",0.9999313107513411,0,0,2
243,Triacylglyceride synthesis WP325,0.5868341354670087,1.0577536694320357,0.5637965223666689,"['LIPE', 'AGPAT1']",0.9999313107513411,0,0,2
244,Glioblastoma signaling pathways WP2261,0.5899815807113541,0.9678617992177314,0.5107057913562191,"['CDKN1B', 'PRKCH', 'CDKN2A', 'PRKCD', 'GAB1', 'SPRY2', 'HRAS', 'FOXO1', 'FGFR2']",0.9999313107513411,0,0,9
245,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.59509771026336,0.9655541947336191,0.5011512731179215,"['SFRP4', 'SFRP1', 'JUN', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.9999313107513411,0,0,7
246,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6100455915207792,0.9517274472168906,0.4703642468897221,"['MYO1E', 'CDKN1B', 'TRPC6', 'INF2', 'TGFB1', 'FAT1']",0.9999313107513411,0,0,6
247,Translation Factors WP107,0.6100455915207792,0.9517274472168906,0.4703642468897221,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H', 'EIF3D']",0.9999313107513411,0,0,6
248,DNA damage response (only ATM dependent) WP710,0.6142549509514531,0.9468373335375719,0.46143663674024327,"['JUN', 'TGFB1', 'CDKN1B', 'WNT5B', 'CDKN2A', 'TCF7', 'BAX', 'HRAS', 'LDLR', 'BBC3']",0.9999313107513411,0,0,10
249,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6250965303231765,0.9400070997515086,0.441661576907836,"['MAP1LC3A', 'IGFBP5', 'IGF1', 'PLD1']",0.9999313107513411,0,0,4
250,Integrated Cancer Pathway WP1971,0.6250965303231765,0.9400070997515086,0.441661576907836,"['CDKN1B', 'BAX', 'BACH1', 'BBC3']",0.9999313107513411,0,0,4
251,Target Of Rapamycin (TOR) Signaling WP1471,0.6250965303231765,0.9400070997515086,0.441661576907836,"['IDI1', 'RRAGA', 'DDIT4', 'HMGCR']",0.9999313107513411,0,0,4
252,Canonical and non-canonical Notch signaling WP3845,0.6255725860952023,0.9762898237690835,0.45796575385644184,"['MAML2', 'PSEN2']",0.9999313107513411,0,0,2
253,Hematopoietic Stem Cell Differentiation WP2849,0.6255725860952023,0.9762898237690835,0.45796575385644184,"['PIM1', 'RUNX1']",0.9999313107513411,0,0,2
254,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6255725860952023,0.9762898237690835,0.45796575385644184,"['JUN', 'MYLK']",0.9999313107513411,0,0,2
255,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.6255725860952023,0.9762898237690835,0.45796575385644184,"['EIF3I', 'EIF3D']",0.9999313107513411,0,0,2
256,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6255725860952023,0.9762898237690835,0.45796575385644184,"['JUN', 'SRXN1']",0.9999313107513411,0,0,2
257,Striated Muscle Contraction Pathway WP383,0.6255725860952023,0.9762898237690835,0.45796575385644184,"['TNNT2', 'ACTG1']",0.9999313107513411,0,0,2
258,Toll-like Receptor Signaling related to MyD88 WP3858,0.6255725860952023,0.9762898237690835,0.45796575385644184,"['TICAM2', 'TIRAP']",0.9999313107513411,0,0,2
259,Vitamin A and carotenoid metabolism WP716,0.6255725860952023,0.9762898237690835,0.45796575385644184,"['CD36', 'RXRG']",0.9999313107513411,0,0,2
260,ATM Signaling Network in Development and Disease  WP3878,0.6281016356605471,0.9330336994132692,0.43391038728692466,"['DCLRE1C', 'KAT5', 'HSPB1', 'HMGN1', 'CDK5R1']",0.9999313107513411,0,0,5
261,G1 to S cell cycle control WP45,0.6281016356605471,0.9330336994132692,0.43391038728692466,"['CDKN1B', 'CDKN2A', 'GADD45A', 'RPA3', 'POLE2']",0.9999313107513411,0,0,5
262,Calcium Regulation in the Cardiac Cell WP536,0.6352835500871586,0.9346285327466577,0.42402586562285033,"['RYR1', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'ATP1B2', 'ATP1B1', 'GJD2', 'RGS2', 'PRKAR1A', 'GNG4', 'PRKD1', 'CALR']",0.9999313107513411,0,0,14
263,HIF1A and PPARG regulation of glycolysis WP2456,0.6410570792649248,1.0577168367346939,0.4702998071796246,['LDHA'],0.9999313107513411,0,0,1
264,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.6410570792649248,1.0577168367346939,0.4702998071796246,['TGFB1'],0.9999313107513411,0,0,1
265,Neuroinflammation WP4919,0.6410570792649248,1.0577168367346939,0.4702998071796246,['JUN'],0.9999313107513411,0,0,1
266,Thiamine metabolic pathways WP4297,0.6410570792649248,1.0577168367346939,0.4702998071796246,['BCKDK'],0.9999313107513411,0,0,1
267,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.6507794749666264,0.9063441350981287,0.3893513398014968,"['HSP90AA1', 'JUN', 'CDKN2A', 'BAX']",0.9999313107513411,0,0,4
268,Regulation of Microtubule Cytoskeleton WP2038,0.6510778815743974,0.9062842528315674,0.388910145501389,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2', 'EPHB2']",0.9999313107513411,0,0,5
269,The influence of laminopathies on Wnt signaling WP4844,0.6530632393843077,0.9064039408866995,0.3862017785298162,"['CEBPB', 'TCF7', 'RUNX2']",0.9999313107513411,0,0,3
270,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6614278960036198,0.9064636703436959,0.374690657850716,"['H3F3B', 'H2AFZ']",0.9999313107513411,0,0,2
271,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6614278960036198,0.9064636703436959,0.374690657850716,"['BAX', 'BBC3']",0.9999313107513411,0,0,2
272,Monoamine Transport WP727,0.6614278960036198,0.9064636703436959,0.374690657850716,"['SLC6A1', 'AGT']",0.9999313107513411,0,0,2
273,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6614278960036198,0.9064636703436959,0.374690657850716,"['PTGES2', 'HRAS']",0.9999313107513411,0,0,2
274,SARS-CoV-2 mitochondrial interactions WP5038,0.6614278960036198,0.9064636703436959,0.374690657850716,"['NDUFB9', 'PHB']",0.9999313107513411,0,0,2
275,Non-small cell lung cancer WP4255,0.6736851854362966,0.8879513444302176,0.3507339980872135,"['CDKN2A', 'GADD45A', 'CYCS', 'BAX', 'HRAS', 'RXRG', 'GADD45G']",0.9999313107513411,0,0,7
276,Wnt signaling pathway and pluripotency WP399,0.675171307076342,0.8901176708587613,0.3496282803211449,"['JUN', 'PRKCH', 'WNT5B', 'PRKCD', 'TCF7', 'ZBTB33', 'PRKD1', 'LDLR']",0.9999313107513411,0,0,8
277,Prader-Willi and Angelman Syndrome WP3998,0.6752605832160363,0.8750027542139474,0.34357561818399796,"['DLX5', 'CDKN2A', 'NDN', 'GABRD']",0.9999313107513411,0,0,4
278,Melatonin metabolism and effects WP3298,0.6809268345299331,0.8651166840822013,0.3324647023483144,"['PER2', 'APOE', 'FOXO1']",0.9999313107513411,0,0,3
279,Nuclear receptors WP170,0.6809268345299331,0.8651166840822013,0.3324647023483144,"['NR2E1', 'NR2F2', 'RXRG']",0.9999313107513411,0,0,3
280,Oxidative Damage WP3941,0.6809268345299331,0.8651166840822013,0.3324647023483144,"['CDKN1B', 'GADD45A', 'CYCS']",0.9999313107513411,0,0,3
281,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6809268345299331,0.8651166840822013,0.3324647023483144,"['CDKN1B', 'HRAS', 'FOXO1']",0.9999313107513411,0,0,3
282,Estrogen Receptor Pathway WP2881,0.6899484366993425,0.9065233236151603,0.3364456282219705,['JUN'],0.9999313107513411,0,0,1
283,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.6899484366993425,0.9065233236151603,0.3364456282219705,['ELOB'],0.9999313107513411,0,0,1
284,ID signaling pathway WP53,0.6899484366993425,0.9065233236151603,0.3364456282219705,['ID2'],0.9999313107513411,0,0,1
285,Mitochondrial CII Assembly WP4920,0.6899484366993425,0.9065233236151603,0.3364456282219705,['SDHAF1'],0.9999313107513411,0,0,1
286,NLR Proteins WP288,0.6899484366993425,0.9065233236151603,0.3364456282219705,['EPHB2'],0.9999313107513411,0,0,1
287,Serotonin and anxiety-related events WP3944,0.6899484366993425,0.9065233236151603,0.3364456282219705,['CRH'],0.9999313107513411,0,0,1
288,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.6899484366993425,0.9065233236151603,0.3364456282219705,['TGFB1'],0.9999313107513411,0,0,1
289,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6922992412091408,0.8648577909614378,0.3180401985275697,"['ANGPT2', 'FN1', 'BAX', 'HRAS', 'ANGPTL1', 'FOXO1']",0.9999313107513411,0,0,6
290,NAD+ biosynthetic pathways WP3645,0.6944666956908525,0.84594767070836,0.3084418873320841,"['NMNAT1', 'ACMSD']",0.9999313107513411,0,0,2
291,Ebola Virus Pathway on Host WP4217,0.6944688952252277,0.8806392986957451,0.32108804983157724,"['ITGA1', 'VPS4A', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'MFGE8', 'MERTK', 'ASGR1', 'ACTG1']",0.9999313107513411,0,0,10
292,Cytosolic DNA-sensing pathway WP4655,0.6985228523197742,0.8457507987220447,0.30344471704852705,"['POLR1C', 'POLR2E', 'POLR2K', 'POLR2L']",0.9999313107513411,0,0,4
293,Alpha 6 Beta 4 signaling pathway WP244,0.7070894729172933,0.8274196235215725,0.28678204307742877,"['PRKCD', 'GAB1', 'HRAS']",0.9999313107513411,0,0,3
294,Nanoparticle-mediated activation of receptor signaling WP2643,0.7070894729172933,0.8274196235215725,0.28678204307742877,"['ITGA1', 'FN1', 'HRAS']",0.9999313107513411,0,0,3
295,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7143939576590849,0.8344831067438417,0.2806539487564398,"['DCLRE1C', 'KAT5', 'CDKN2A', 'ACTL6A', 'BAX']",0.9999313107513411,0,0,5
296,Interleukin-11 Signaling Pathway WP2332,0.7205618405118247,0.8183860661651036,0.26820478561652894,"['TGFB1', 'IL6ST', 'HRAS', 'RUNX2']",0.9999313107513411,0,0,4
297,Cell cycle WP179,0.7235829945590319,0.8516073478760046,0.27552906423949,"['TGFB1', 'CDKN1B', 'DBF4', 'GADD45A', 'CDKN2A', 'BUB3', 'CDC14B', 'ANAPC11', 'GADD45G']",0.9999313107513411,0,0,9
298,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7247908920857422,0.792996171027441,0.25524333527887544,"['SGK1', 'FOXO1']",0.9999313107513411,0,0,2
299,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7247908920857422,0.792996171027441,0.25524333527887544,"['LDHA', 'PDHB']",0.9999313107513411,0,0,2
300,Oxidation by Cytochrome P450 WP43,0.7247908920857422,0.792996171027441,0.25524333527887544,"['CYB5R1', 'CYP51A1']",0.9999313107513411,0,0,2
301,Trans-sulfuration and one-carbon metabolism WP2525,0.7247908920857422,0.792996171027441,0.25524333527887544,"['AHCY', 'GSS']",0.9999313107513411,0,0,2
302,Tryptophan metabolism WP465,0.7247908920857422,0.792996171027441,0.25524333527887544,"['DHCR24', 'ACMSD']",0.9999313107513411,0,0,2
303,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7315727699145435,0.7928639846743295,0.24781644361478164,"['PRKCH', 'PRKCD', 'HRAS']",0.9999313107513411,0,0,3
304,miRNA regulation of prostate cancer signaling pathways WP3981,0.7315727699145435,0.7928639846743295,0.24781644361478164,"['CDKN1B', 'TCF7', 'FOXO1']",0.9999313107513411,0,0,3
305,Neural Crest Cell Migration during Development WP4564,0.7315727699145435,0.7928639846743295,0.24781644361478164,"['JUN', 'EPHB2', 'EPHB3']",0.9999313107513411,0,0,3
306,Prion disease pathway WP3995,0.7315727699145435,0.7928639846743295,0.24781644361478164,"['PRNP', 'HSPA5', 'RFX5']",0.9999313107513411,0,0,3
307,15q11.2 copy number variation syndrome WP4940,0.7321839728569103,0.7931281887755102,0.24723666922403614,['TUBGCP4'],0.9999313107513411,0,0,1
308,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.7321839728569103,0.7931281887755102,0.24723666922403614,['GABBR1'],0.9999313107513411,0,0,1
309,Hypertrophy Model WP516,0.7321839728569103,0.7931281887755102,0.24723666922403614,['WDR1'],0.9999313107513411,0,0,1
310,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.7321839728569103,0.7931281887755102,0.24723666922403614,['JUN'],0.9999313107513411,0,0,1
311,miRNAs involved in DNA damage response WP1545,0.7321839728569103,0.7931281887755102,0.24723666922403614,['CDKN1B'],0.9999313107513411,0,0,1
312,Non-homologous end joining WP438,0.7321839728569103,0.7931281887755102,0.24723666922403614,['DCLRE1C'],0.9999313107513411,0,0,1
313,Purine metabolism WP4792,0.7321839728569103,0.7931281887755102,0.24723666922403614,['PRPS1'],0.9999313107513411,0,0,1
314,RAS and bradykinin pathways in COVID-19 WP4969,0.7321839728569103,0.7931281887755102,0.24723666922403614,['AGT'],0.9999313107513411,0,0,1
315,TCA cycle in senescence WP5050,0.7321839728569103,0.7931281887755102,0.24723666922403614,['GOT1'],0.9999313107513411,0,0,1
316,G Protein Signaling Pathways WP35,0.7380528688166411,0.8389988687782806,0.25483736453100964,"['GNA14', 'PRKCH', 'PRKD3', 'PRKAR1A', 'GNG4', 'PDE1A', 'PRKCD', 'PRKD1', 'HRAS']",0.9999313107513411,0,0,9
317,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7395353656620022,0.8314132386763424,0.2508649555995977,"['SHC3', 'HGF', 'PDGFC', 'GAB1', 'BAX', 'IGF1', 'HRAS', 'FGFR2']",0.9999313107513411,0,0,8
318,Metabolic reprogramming in colon cancer WP4290,0.7413840163203138,0.7927316293929713,0.23721427569774337,"['LDHA', 'PKM', 'PGAM1', 'PDHB']",0.9999313107513411,0,0,4
319,Pathogenic Escherichia coli infection WP2272,0.7413840163203138,0.7927316293929713,0.23721427569774337,"['TUBB2B', 'TUBB2A', 'TUBB', 'ACTG1']",0.9999313107513411,0,0,4
320,PI3K-Akt signaling pathway WP4172,0.7417059502913604,0.882888392332118,0.2638091774189122,"['HSP90AA1', 'CDKN1B', 'ANGPT2', 'HGF', 'F2R', 'ITGA1', 'FN1', 'VEGFB', 'PPP2R5B', 'IGF1', 'FGF1', 'EFNA3', 'RELN', 'FGF9', 'IL7', 'GNG4', 'DDIT4', 'PDGFC', 'KIT', 'COL6A6', 'SGK1', 'HRAS', 'FGFR2']",0.9999313107513411,0,0,23
321,MECP2 and Associated Rett Syndrome WP3584,0.7420076025240692,0.8218452126902831,0.24523515139811639,"['DLX5', 'SST', 'GAD1', 'OPRK1', 'IGF1', 'SGK1', 'FKBP5']",0.9999313107513411,0,0,7
322,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.7495656374668385,0.8449582530507386,0.24356884074296428,"['DLX2', 'JUN', 'CEBPB', 'VIPR2', 'PRKAR1A', 'SST', 'PAH', 'SLC1A3', 'ATP1A3', 'AQP4', 'TAC1', 'ASCL1']",0.9999313107513411,0,0,12
323,Gastrin signaling pathway WP4659,0.7506331462666852,0.8339522635967725,0.23920939416490936,"['JUN', 'PRKCH', 'CDKN1B', 'KAT5', 'CDKN2A', 'PRKCD', 'KIT', 'PRKD1', 'HRAS', 'FOXO1']",0.9999313107513411,0,0,10
324,AGE/RAGE pathway WP2324,0.7518261598278467,0.792599104859335,0.2260890152931204,"['JUN', 'PRKCD', 'CYCS', 'TIRAP', 'FOXO1']",0.9999313107513411,0,0,5
325,Gastric Cancer Network 2 WP2363,0.7525268409392207,0.7462742595442772,0.21217966311736355,"['FANCI', 'DSCC1']",0.9999313107513411,0,0,2
326,Glycerolipids and Glycerophospholipids WP4722,0.7525268409392207,0.7462742595442772,0.21217966311736355,"['PLD1', 'CDIPT']",0.9999313107513411,0,0,2
327,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7525268409392207,0.7462742595442772,0.21217966311736355,"['GNA14', 'TRPC3']",0.9999313107513411,0,0,2
328,Melanoma WP4685,0.7621620411434632,0.7924664107485605,0.21523078137625404,"['CDKN2A', 'GADD45A', 'KIT', 'BAX', 'HRAS', 'GADD45G']",0.9999313107513411,0,0,6
329,Pathways Regulating Hippo Signaling WP4540,0.7682025753537883,0.8048564717366767,0.21224210888919773,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'TCF7', 'KIT', 'FGFR2', 'CDH18']",0.9999313107513411,0,0,8
330,Canonical and non-canonical TGF-B signaling WP3874,0.7686692768471177,0.7049319727891157,0.18546370454399927,['TGFB1'],0.9999313107513411,0,0,1
331,Ganglio Sphingolipid Metabolism WP1423,0.7686692768471177,0.7049319727891157,0.18546370454399927,['B3GALT1'],0.9999313107513411,0,0,1
332,Hedgehog Signaling Pathway Netpath WP47,0.7686692768471177,0.7049319727891157,0.18546370454399927,['GLI3'],0.9999313107513411,0,0,1
333,"NAD metabolism, sirtuins and aging WP3630",0.7686692768471177,0.7049319727891157,0.18546370454399927,['FOXO1'],0.9999313107513411,0,0,1
334,RalA downstream regulated genes WP2290,0.7686692768471177,0.7049319727891157,0.18546370454399927,['HRAS'],0.9999313107513411,0,0,1
335,Acute viral myocarditis WP4298,0.7691164517963723,0.7731894454494417,0.20297219443225897,"['ENDOG', 'CXADR', 'TGFB1', 'CYCS', 'BAX']",0.9999313107513411,0,0,5
336,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7691164517963723,0.7731894454494417,0.20297219443225897,"['JUN', 'CDKN1B', 'TMSB4X', 'FN1', 'MYLK']",0.9999313107513411,0,0,5
337,Type 2 papillary renal cell carcinoma WP4241,0.7756614598325937,0.731727085175361,0.18588730267001694,"['TGFB1', 'COL21A1', 'ELOB']",0.9999313107513411,0,0,3
338,Endothelin Pathways WP2197,0.7778168106464919,0.7047436715592427,0.17707688614637815,"['ADCY10', 'MYLK']",0.9999313107513411,0,0,2
339,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7778168106464919,0.7047436715592427,0.17707688614637815,"['FGF9', 'PTHLH']",0.9999313107513411,0,0,2
340,Metapathway biotransformation Phase I and II WP702,0.781654637958194,0.7922005124919923,0.19515247684242246,"['NNMT', 'GPX4', 'GSS', 'CYP51A1', 'KCNAB1', 'SULT4A1', 'GAL3ST3', 'FMO5']",0.9999313107513411,0,0,8
341,Small cell lung cancer WP4658,0.7861928224309441,0.7783543365455893,0.18723562287197756,"['CDKN1B', 'GADD45A', 'FN1', 'CYCS', 'BAX', 'RXRG', 'GADD45G']",0.9999313107513411,0,0,7
342,Head and Neck Squamous Cell Carcinoma WP4674,0.7923831742819967,0.7606142034548944,0.17700268207961412,"['CDKN2A', 'DDIT4', 'GAB1', 'FAT1', 'HRAS', 'FGFR2']",0.9999313107513411,0,0,6
343,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7953745892183319,0.7045551298424861,0.16130232668862987,"['IFITM3', 'JUN', 'DDIT3']",0.9999313107513411,0,0,3
344,IL-2 signaling pathway WP49,0.7953745892183319,0.7045551298424861,0.16130232668862987,"['JUN', 'PTK2B', 'HRAS']",0.9999313107513411,0,0,3
345,Neural Crest Cell Migration in Cancer WP4565,0.7953745892183319,0.7045551298424861,0.16130232668862987,"['JUN', 'EPHB2', 'EPHB3']",0.9999313107513411,0,0,3
346,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7967459039148365,0.7245641259698767,0.1646350742853202,"['CEBPB', 'TGFB1', 'TCF7', 'RUNX2']",0.9999313107513411,0,0,4
347,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8001867918233514,0.634375,0.14140858757584962,['RPH3AL'],0.9999313107513411,0,0,1
348,FOXA2 pathway WP5066,0.8001867918233514,0.634375,0.14140858757584962,['FOXO1'],0.9999313107513411,0,0,1
349,Leptin Insulin Overlap WP3935,0.8001867918233514,0.634375,0.14140858757584962,['LEPR'],0.9999313107513411,0,0,1
350,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8001867918233514,0.634375,0.14140858757584962,['SFRP4'],0.9999313107513411,0,0,1
351,Riboflavin and CoQ disorders WP5037,0.8001867918233514,0.634375,0.14140858757584962,['RFK'],0.9999313107513411,0,0,1
352,Serotonin and anxiety WP3947,0.8001867918233514,0.634375,0.14140858757584962,['CRH'],0.9999313107513411,0,0,1
353,Neural Crest Differentiation WP2064,0.8009162260403208,0.7370784511984774,0.1636306231430273,"['DLX5', 'LHX2', 'ASCL1', 'FGFR2', 'GFAP']",0.9999313107513411,0,0,5
354,Rett syndrome causing genes WP4312,0.8009162260403208,0.7370784511984774,0.1636306231430273,"['KCNJ10', 'SATB2', 'IMPDH2', 'HAP1', 'GABRD']",0.9999313107513411,0,0,5
355,Nucleotide Excision Repair WP4753,0.8129312144819794,0.7043663471778487,0.14588045487012302,"['POLE4', 'RPA3', 'POLE2', 'POLE3']",0.9999313107513411,0,0,4
356,Vitamin D-sensitive calcium signaling in depression WP4698,0.8136186370345773,0.6793240284619595,0.14011977051698218,"['GPX4', 'ATP2B4', 'PVALB']",0.9999313107513411,0,0,3
357,Ethanol effects on histone modifications WP3996,0.8216689613618615,0.6341416719846841,0.12455664135779489,"['AHCY', 'HAT1']",0.9999313107513411,0,0,2
358,MTHFR deficiency WP4288,0.8216689613618615,0.6341416719846841,0.12455664135779489,"['CHDH', 'CYCS']",0.9999313107513411,0,0,2
359,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8274125511219039,0.5766465677179963,0.10924676234747899,['ABCB1'],0.9999313107513411,0,0,1
360,Omega-3/Omega-6 FA synthesis WP4723,0.8274125511219039,0.5766465677179963,0.10924676234747899,['ACOT2'],0.9999313107513411,0,0,1
361,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8274125511219039,0.5766465677179963,0.10924676234747899,['LDHA'],0.9999313107513411,0,0,1
362,DNA Repair Pathways Full Network WP4946,0.827513927250962,0.7740479246897732,0.1465499837608813,"['FANCI', 'POLE4', 'BRIP1', 'DCLRE1C', 'NEIL2', 'CENPX', 'RPA3', 'POLE2', 'APEX1', 'POLE3', 'FAAP100']",0.9999313107513411,0,0,11
363,Focal Adhesion WP306,0.8278669549491164,0.7979948736251258,0.15074348192248577,"['JUN', 'SHC3', 'HGF', 'ITGA1', 'FN1', 'VEGFB', 'TESK2', 'IGF1', 'MYLK', 'ACTG1', 'RELN', 'COL5A3', 'PDGFC', 'COL5A2', 'HRAS']",0.9999313107513411,0,0,15
364,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.82804474251872,0.6852603402124169,0.12930046419816643,"['ADCY10', 'TGFB1', 'BANF1', 'HRAS']",0.9999313107513411,0,0,4
365,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.82804474251872,0.6852603402124169,0.12930046419816643,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'PIM1']",0.9999313107513411,0,0,4
366,Wnt signaling WP428,0.8359463043115911,0.7270208433911967,0.1302755172485959,"['SFRP4', 'SFRP1', 'JUN', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.9999313107513411,0,0,7
367,IL17 signaling pathway WP2112,0.8405425365136417,0.6038836721670161,0.10489925513170834,"['CEBPB', 'TRAF3IP2']",0.9999313107513411,0,0,2
368,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8405425365136417,0.6038836721670161,0.10489925513170834,"['TGFB1', 'BAX']",0.9999313107513411,0,0,2
369,Sphingolipid pathway WP1422,0.8405425365136417,0.6038836721670161,0.10489925513170834,"['CERS4', 'SERINC1']",0.9999313107513411,0,0,2
370,AMP-activated protein kinase (AMPK) signaling WP1403,0.842000664819912,0.6887996219281664,0.11845595347686172,"['LIPE', 'STRADB', 'LEPR', 'HMGCR', 'ADIPOR1']",0.9999313107513411,0,0,5
371,16p11.2 proximal deletion syndrome WP4949,0.8438576940935894,0.7039880571550438,0.11951704332366296,"['ASPHD1', 'IGFBP3', 'KCTD13', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9999313107513411,0,0,6
372,IL-3 signaling pathway WP286,0.8459843522706554,0.6339080459770114,0.10602391982533559,"['JUN', 'TGFB1', 'HRAS']",0.9999313107513411,0,0,3
373,Apoptosis Modulation by HSP70 WP384,0.8509306421806743,0.5285395408163265,0.08531931317839916,['CYCS'],0.9999313107513411,0,0,1
374,Globo Sphingolipid Metabolism WP1424,0.8509306421806743,0.5285395408163265,0.08531931317839916,['B3GALNT1'],0.9999313107513411,0,0,1
375,Heart Development WP1591,0.8509306421806743,0.5285395408163265,0.08531931317839916,['VEGFB'],0.9999313107513411,0,0,1
376,MAPK pathway in congenital thyroid cancer WP4928,0.8509306421806743,0.5285395408163265,0.08531931317839916,['JUN'],0.9999313107513411,0,0,1
377,NAD+ metabolism WP3644,0.8509306421806743,0.5285395408163265,0.08531931317839916,['NMNAT1'],0.9999313107513411,0,0,1
378,Nicotine Activity on Dopaminergic Neurons WP1602,0.8509306421806743,0.5285395408163265,0.08531931317839916,['CHRNA6'],0.9999313107513411,0,0,1
379,Pancreatic adenocarcinoma pathway WP4263,0.8571277890281822,0.7037985488689714,0.1085033972817907,"['TGFB1', 'CDKN2A', 'GADD45A', 'PRKCD', 'BAX', 'PLD1', 'GADD45G']",0.9999313107513411,0,0,7
380,Lipid Metabolism Pathway WP3965,0.8575860709162988,0.5763763996054998,0.08855085657772466,"['LIPE', 'PRKAR1A']",0.9999313107513411,0,0,2
381,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8575860709162988,0.5763763996054998,0.08855085657772466,"['AGT', 'CAMK1G']",0.9999313107513411,0,0,2
382,Signal transduction through IL1R WP4496,0.8575860709162988,0.5763763996054998,0.08855085657772466,"['JUN', 'TGFB1']",0.9999313107513411,0,0,2
383,Glycogen Synthesis and Degradation WP500,0.8602547894242158,0.6133976022741318,0.09233269651832489,"['PHKG1', 'PPP2R5B', 'GYG1']",0.9999313107513411,0,0,3
384,Amino Acid metabolism WP3925,0.865421564650326,0.678708527556896,0.09809953476739505,"['LDHA', 'PKM', 'GOT1', 'GSS', 'ODC1', 'SRM']",0.9999313107513411,0,0,6
385,Cardiac Hypertrophic Response WP2795,0.867394646540408,0.6336741214057507,0.09014725324277371,"['TGFB1', 'PRKD1', 'IGF1', 'FGFR2']",0.9999313107513411,0,0,4
386,Urea cycle and associated pathways WP4595,0.8712457049374261,0.4878335949764521,0.06723871257291004,['GOT1'],0.9999313107513411,0,0,1
387,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8752412912424709,0.6667340135367209,0.08884608716540407,"['TGFB1', 'IGF1', 'IL6ST', 'AGT', 'FGFR2', 'MYLK']",0.9999313107513411,0,0,6
388,Insulin Signaling WP481,0.8754711418648878,0.7507003106436319,0.09983795374371089,"['XBP1', 'JUN', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'FOXO1', 'LIPE', 'RPS6KA5', 'SGK1', 'GYG1', 'HRAS', 'PFKM', 'ARF6']",0.9999313107513411,0,0,14
389,MET in type 1 papillary renal cell carcinoma WP4205,0.8758338123218548,0.6464324860378934,0.08570331956198517,"['JUN', 'HGF', 'RPL11', 'GAB1', 'HRAS']",0.9999313107513411,0,0,5
390,22q11.2 copy number variation syndrome WP4657,0.8760292595993986,0.6820053186250369,0.0902673508446526,"['RANBP1', 'MRPL40', 'RELN', 'THAP7', 'RCC1', 'DGCR6L', 'FGFR2']",0.9999313107513411,0,0,7
391,Integrated breast cancer pathway WP1984,0.8815744920890821,0.7301763746850453,0.09203564678402476,"['JUN', 'GADD45A', 'DCAKD', 'ODC1', 'BAX', 'PHB', 'HMGCR', 'FAU', 'JAKMIP1', 'BACH1', 'RPP38', 'FOXO1']",0.9999313107513411,0,0,12
392,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8856512583325954,0.6334398976982097,0.07691988599880523,"['JUN', 'CDKN1B', 'APEX1', 'PLD1', 'HRAS']",0.9999313107513411,0,0,5
393,PDGFR-beta pathway WP3972,0.8867691868376907,0.5282386726228462,0.06347873092522319,"['JUN', 'HRAS']",0.9999313107513411,0,0,2
394,Ebstein-Barr virus LMP1 signaling WP262,0.8887937319840696,0.45294278425655976,0.053397466916531924,['HSP90AA1'],0.9999313107513411,0,0,1
395,Pathways in clear cell renal cell carcinoma WP4018,0.8930831164806369,0.6440027326848629,0.07282101270476993,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM', 'KCNJ2']",0.9999313107513411,0,0,6
396,B Cell Receptor Signaling Pathway WP23,0.9011572225873213,0.6332053742802303,0.06590119044837522,"['JUN', 'CD81', 'PRKCD', 'GAB1', 'HRAS', 'FOXO1']",0.9999313107513411,0,0,6
397,Hepatitis B infection WP4666,0.9030458848578452,0.6878015450260758,0.07014331736742799,"['JUN', 'TICAM2', 'TGFB1', 'ATP6AP1', 'VDAC3', 'CYCS', 'PTK2B', 'BAX', 'HRAS', 'TIRAP']",0.9999313107513411,0,0,10
398,Immune response to tuberculosis WP4197,0.9039514019814731,0.42270408163265305,0.04268452243512878,['IFIT3'],0.9999313107513411,0,0,1
399,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.9039514019814731,0.42270408163265305,0.04268452243512878,['CEBPB'],0.9999313107513411,0,0,1
400,Regulation of Actin Cytoskeleton WP51,0.9047670114795096,0.6959370988446727,0.06964786374689268,"['FGF9', 'CFL2', 'TMSB4X', 'CHRM5', 'F2R', 'ITGA1', 'FN1', 'FGF1', 'FGFR2', 'MYLK', 'ACTG1']",0.9999313107513411,0,0,11
401,3q29 copy number variation syndrome WP4906,0.9076364764209844,0.575835027592216,0.055804942363225474,"['JUN', 'TGFB1', 'NCBP2', 'WDR34']",0.9999313107513411,0,0,4
402,ATM Signaling Pathway WP2516,0.9103210672490939,0.4875067497913701,0.04580512046211586,"['JUN', 'GADD45A']",0.9999313107513411,0,0,2
403,Retinoblastoma gene in cancer WP2446,0.9111988399228735,0.597403850793804,0.05555505732599699,"['ANLN', 'CDKN1B', 'H2AFZ', 'RPA3', 'POLE2']",0.9999313107513411,0,0,5
404,Hippo-Merlin Signaling Dysregulation WP4541,0.9143556517037043,0.6329705505761843,0.05667344079436936,"['PPP1R14A', 'PRKAR1A', 'ITGA1', 'KIT', 'HRAS', 'FGFR2', 'CDH18']",0.9999313107513411,0,0,7
405,IL-4 signaling pathway WP395,0.9154692851006018,0.5279374201787995,0.04662662272103554,"['CEBPB', 'HRH1', 'NFIL3']",0.9999313107513411,0,0,3
406,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.917044144320902,0.3962452168367347,0.03431470420436499,['H3F3B'],0.9999313107513411,0,0,1
407,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.917044144320902,0.3962452168367347,0.03431470420436499,['HRAS'],0.9999313107513411,0,0,1
408,Mitochondrial Gene Expression WP391,0.917044144320902,0.3962452168367347,0.03431470420436499,['PPRC1'],0.9999313107513411,0,0,1
409,Oxidative Stress WP408,0.917044144320902,0.3962452168367347,0.03431470420436499,['TXN2'],0.9999313107513411,0,0,1
410,Purine metabolism and related disorders WP4224,0.917044144320902,0.3962452168367347,0.03431470420436499,['PRPS1'],0.9999313107513411,0,0,1
411,TLR4 Signaling and Tolerance WP3851,0.917044144320902,0.3962452168367347,0.03431470420436499,['TIRAP'],0.9999313107513411,0,0,1
412,Alzheimer's disease WP2059,0.9185260067161308,0.5862816140949133,0.049825178381406134,"['ATP5MD', 'PSEN2', 'CYCS', 'APOE', 'CDK5R1']",0.9999313107513411,0,0,5
413,CAMKK2  Pathway WP4874,0.9202958156444351,0.4694036729773807,0.03898872628729597,"['FIS1', 'MAP1LC3A']",0.9999313107513411,0,0,2
414,Hedgehog Signaling Pathway WP4249,0.9202958156444351,0.4694036729773807,0.03898872628729597,"['HHIP', 'GLI3']",0.9999313107513411,0,0,2
415,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9202958156444351,0.4694036729773807,0.03898872628729597,"['JUN', 'TGFB1']",0.9999313107513411,0,0,2
416,IL-5 signaling pathway WP127,0.9202958156444351,0.4694036729773807,0.03898872628729597,"['SPRED1', 'JUN']",0.9999313107513411,0,0,2
417,Ectoderm Differentiation WP2858,0.9204831389575245,0.6658789372404713,0.055172461915922684,"['PPFIBP2', 'MAFB', 'PIM1', 'SPRY2', 'ROR2', 'NR2F2', 'JAKMIP1', 'PTPN13', 'FGFR2', 'GLI3']",0.9999313107513411,0,0,10
418,7q11.23 copy number variation syndrome WP4932,0.9206566675037762,0.623992353609493,0.05158425887117265,"['ATP5MC2', 'EIF4H', 'ATP5MC3', 'UBE2L6', 'GTF2IRD1', 'ATP5F1E', 'ATP5MC1']",0.9999313107513411,0,0,7
419,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9237831526571204,0.5136170653412033,0.04071849166882088,"['MAP1LC3A', 'GTPBP2', 'FTL']",0.9999313107513411,0,0,3
420,Circadian rhythm related genes WP3594,0.9238633641892112,0.6907066168369661,0.05469781160434861,"['JUN', 'AHCY', 'RBM4B', 'HCRTR2', 'CIART', 'PER2', 'HTR7', 'DBP', 'NFIL3', 'ID2', 'CRH', 'ATF5', 'RPS27A']",0.9999313107513411,0,0,13
421,Endoderm differentiation WP2853,0.9253958039976228,0.6470061188811189,0.05016480211478874,"['DUSP4', 'SFRP1', 'TGFB1', 'TCF7', 'SLC2A12', 'NOG', 'PBX3', 'FOXO1', 'PTHLH']",0.9999313107513411,0,0,9
422,16p11.2 distal deletion syndrome WP4950,0.9283531081299228,0.37289915966386555,0.027722484781788105,['CD81'],0.9999313107513411,0,0,1
423,1q21.1 copy number variation syndrome WP4905,0.9283531081299228,0.37289915966386555,0.027722484781788105,['FMO5'],0.9999313107513411,0,0,1
424,Fluoropyrimidine Activity WP1601,0.9283531081299228,0.37289915966386555,0.027722484781788105,['DPYD'],0.9999313107513411,0,0,1
425,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9283531081299228,0.37289915966386555,0.027722484781788105,['MAP1LC3A'],0.9999313107513411,0,0,1
426,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.9283531081299228,0.37289915966386555,0.027722484781788105,['GOT1'],0.9999313107513411,0,0,1
427,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9283531081299228,0.37289915966386555,0.027722484781788105,['FOXO1'],0.9999313107513411,0,0,1
428,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.9283531081299228,0.37289915966386555,0.027722484781788105,['HRAS'],0.9999313107513411,0,0,1
429,Vitamin D in inflammatory diseases WP4482,0.9283531081299228,0.37289915966386555,0.027722484781788105,['DUSP1'],0.9999313107513411,0,0,1
430,Wnt signaling in kidney disease WP4150,0.9283531081299228,0.37289915966386555,0.027722484781788105,['WNT5B'],0.9999313107513411,0,0,1
431,Amyotrophic lateral sclerosis (ALS) WP2447,0.9292187234422873,0.45259367307867626,0.03322541216678111,"['TOMM40', 'BAX']",0.9999313107513411,0,0,2
432,MAPK Cascade WP422,0.9292187234422873,0.45259367307867626,0.03322541216678111,"['JUN', 'HRAS']",0.9999313107513411,0,0,2
433,TGF-beta Signaling Pathway WP366,0.9304981250884079,0.6396715643906655,0.04607888049494695,"['TGFBR3', 'JUN', 'TGFB1', 'PARD6A', 'SUMO1', 'FN1', 'STRAP', 'NEDD9', 'RUNX2']",0.9999313107513411,0,0,9
434,Netrin-UNC5B signaling pathway WP4747,0.9371911067330487,0.4369429835178135,0.028343644362426475,"['JUN', 'PTK2B']",0.9999313107513411,0,0,2
435,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9371911067330487,0.4369429835178135,0.028343644362426475,"['TGFB1', 'IFIT2']",0.9999313107513411,0,0,2
436,DNA IR-damage and cellular response via ATR WP4016,0.9373994816811526,0.5552564275137973,0.03589496621451958,"['FANCI', 'SEM1', 'BRIP1', 'POLN', 'ABRAXAS1']",0.9999313107513411,0,0,5
437,Fatty Acid Biosynthesis WP357,0.9381211838746548,0.3521471088435374,0.022493799583161528,['SCD'],0.9999313107513411,0,0,1
438,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9443062086337602,0.4223356732610083,0.024201857860419118,"['PDE3A', 'CYCS']",0.9999313107513411,0,0,2
439,Estrogen signaling pathway WP712,0.946558206911646,0.33357948442534907,0.018321123717921856,['JUN'],0.9999313107513411,0,0,1
440,Sphingolipid Metabolism (general overview) WP4725,0.946558206911646,0.33357948442534907,0.018321123717921856,['CERS4'],0.9999313107513411,0,0,1
441,G13 Signaling Pathway WP524,0.9506495187540349,0.4086707701175453,0.020682755772071727,"['CFL2', 'IQGAP2']",0.9999313107513411,0,0,2
442,Leptin signaling pathway WP2034,0.9522502830215193,0.5273337595907929,0.025801057349202187,"['CFL2', 'LEPR', 'BAX', 'HRAS', 'FOXO1']",0.9999313107513411,0,0,5
443,Cannabinoid receptor signaling WP3869,0.9538454532866932,0.31686862244897956,0.014973189255954053,['PRKAR1A'],0.9999313107513411,0,0,1
444,Nanoparticle triggered autophagic cell death WP2509,0.9538454532866932,0.31686862244897956,0.014973189255954053,['MAP1LC3A'],0.9999313107513411,0,0,1
445,Sphingolipid Metabolism (integrated pathway) WP4726,0.9538454532866932,0.31686862244897956,0.014973189255954053,['CERS4'],0.9999313107513411,0,0,1
446,Corticotropin-releasing hormone signaling pathway WP2355,0.9564382173742484,0.5186365351557587,0.023099596507104844,"['CRHBP', 'HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.9999313107513411,0,0,5
447,ErbB signaling pathway WP673,0.9569142781470131,0.5421990677268989,0.0238792412942684,"['JUN', 'CDKN1B', 'SHC3', 'GAB1', 'HRAS', 'FOXO1']",0.9999313107513411,0,0,6
448,mRNA Processing WP411,0.9571801401552789,0.6206159453511828,0.027160432059620827,"['PRPF4', 'SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'SNRPE', 'SNU13', 'SNRPA1', 'SRSF9', 'LSM2']",0.9999313107513411,0,0,11
449,TNF-alpha signaling pathway WP231,0.9602879178512377,0.510219866347661,0.02067519323082026,"['HSP90AA1', 'JUN', 'RFK', 'BAX', 'HRAS']",0.9999313107513411,0,0,5
450,PDGF Pathway WP2526,0.9613262826175494,0.38382549167488544,0.015138616121967366,"['JUN', 'HRAS']",0.9999313107513411,0,0,2
451,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9657955632859514,0.37249896767896695,0.01296411858960158,"['JUN', 'LCP2']",0.9999313107513411,0,0,2
452,Pathways affected in adenoid cystic carcinoma WP3651,0.9676856534859135,0.4219667943805875,0.013860757910642547,"['MYCBP', 'HRAS', 'FOXP2']",0.9999313107513411,0,0,3
453,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9702708620530869,0.2754547471162378,0.008313226260811402,['JUN'],0.9999313107513411,0,0,1
454,RANKL/RANK signaling pathway WP2018,0.9732893937559088,0.3517336736864497,0.00952277304672434,"['JUN', 'PAPSS2']",0.9999313107513411,0,0,2
455,Splicing factor NOVA regulated synaptic proteins WP4148,0.9732893937559088,0.3517336736864497,0.00952277304672434,"['NTNG1', 'EPB41']",0.9999313107513411,0,0,2
456,Toll-like Receptor Signaling Pathway WP75,0.9741122972376876,0.40392924105323225,0.01059453366617854,"['JUN', 'TICAM2', 'TIRAP']",0.9999313107513411,0,0,3
457,Glycerophospholipid Biosynthetic Pathway WP2533,0.9743259497580374,0.26395089285714285,0.0068651992444492636,['CDIPT'],0.9999313107513411,0,0,1
458,Histone Modifications WP2369,0.9764147732330074,0.34219286293313095,0.008167394328068798,"['SET', 'H3F3B']",0.9999313107513411,0,0,2
459,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9768510987885012,0.3954741379310345,0.00926241762702989,"['ITGA1', 'TCF7', 'ACTG1']",0.9999313107513411,0,0,3
460,Fatty acid beta-oxidation WP143,0.9778281776178505,0.2533673469387755,0.005680828308326407,['LIPE'],0.9999313107513411,0,0,1
461,Intraflagellar transport proteins binding to dynein WP4532,0.9778281776178505,0.2533673469387755,0.005680828308326407,['WDR34'],0.9999313107513411,0,0,1
462,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9784911353060342,0.5587879682346865,0.012150035054113354,"['LINGO1', 'JUN', 'RAB3A', 'RPS6KA5', 'SHC3', 'PRKCD', 'PTK2B', 'FRS3', 'HRAS', 'CDK5R1']",0.9999313107513411,0,0,10
463,EGF/EGFR signaling pathway WP437,0.9808514724539443,0.5644822943736497,0.010913833392542127,"['NDUFA13', 'JUN', 'RPS6KA5', 'PRKCD', 'GAB1', 'PTK2B', 'SPRY2', 'PLD1', 'HRAS', 'FOXO1', 'ARF6']",0.9999313107513411,0,0,11
464,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9834651279377781,0.23455215419501133,0.003910711260838045,['SUPT4H1'],0.9999313107513411,0,0,1
465,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9834651279377781,0.23455215419501133,0.003910711260838045,['JUN'],0.9999313107513411,0,0,1
466,Energy Metabolism WP1541,0.9838099978570801,0.3164326738991704,0.005164969846205128,"['PPRC1', 'FOXO1']",0.9999313107513411,0,0,2
467,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9840603286112941,0.46804578090566573,0.0075205943576113965,"['TGFB1', 'WNT5B', 'ID2', 'FN1', 'STRAP', 'HRAS']",0.9999313107513411,0,0,6
468,Phosphoinositides metabolism WP4971,0.9857211354911897,0.22615251457725946,0.003252477616931928,['PIP4P1'],0.9999313107513411,0,0,1
469,Male infertility WP4673,0.9861738563036723,0.4013996652974289,0.005588533029687403,"['ABCB1', 'PEX10', 'TEX15', 'ETV5']",0.9999313107513411,0,0,4
470,Kit receptor signaling pathway WP304,0.987429537010813,0.3013036739903364,0.003811533561623853,"['KIT', 'HRAS']",0.9999313107513411,0,0,2
471,Notch Signaling Pathway Netpath WP61,0.987429537010813,0.3013036739903364,0.003811533561623853,"['MAML2', 'PSEN2']",0.9999313107513411,0,0,2
472,MAPK Signaling Pathway WP382,0.9881141724950274,0.5799796290593836,0.00693483307310969,"['DUSP4', 'JUN', 'TGFB1', 'GADD45A', 'DUSP1', 'PRKCD', 'HSPB1', 'FGF1', 'DUSP7', 'RPS6KA5', 'FGF9', 'DDIT3', 'HRAS', 'HSPA1B', 'FGFR2']",0.9999313107513411,0,0,15
473,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9893520307965298,0.21103316326530613,0.002259123621959737,['ACTG1'],0.9999313107513411,0,0,1
474,Notch Signaling WP268,0.9893520307965298,0.21103316326530613,0.002259123621959737,['PSEN2'],0.9999313107513411,0,0,1
475,Regulation of toll-like receptor signaling pathway WP1449,0.9899714336669377,0.3830380482137671,0.003860713706317814,"['JUN', 'TICAM2', 'PELI3', 'TIRAP']",0.9999313107513411,0,0,4
476,Fragile X Syndrome  WP4549,0.9903441938658368,0.48086391507275555,0.004665690669555364,"['PRKAR1A', 'CDKN2A', 'GAD1', 'GAB1', 'PPP2R5B', 'SLC6A1', 'GABRD', 'SHANK1']",0.9999313107513411,0,0,8
477,Disruption of postsynaptic signaling by CNV WP4875,0.9908050856029945,0.20420506912442396,0.0018863338207318117,['SHANK1'],0.9999313107513411,0,0,1
478,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9908050856029945,0.20420506912442396,0.0018863338207318117,['GABRD'],0.9999313107513411,0,0,1
479,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9926591318436446,0.326958647113225,0.0024090133036007502,"['SLCO1C1', 'HRAS', 'FOXO1']",0.9999313107513411,0,0,3
480,Thermogenesis WP4321,0.9939188124844212,0.38978876574784505,0.002377615287730679,"['LIPE', 'ADCY10', 'ACTL6A', 'HRAS', 'ACTG1']",0.9999313107513411,0,0,5
481,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9941701653455818,0.26348117421825146,0.0015405466222621108,"['F2R', 'IL6ST']",0.9999313107513411,0,0,2
482,Chemokine signaling pathway WP3929,0.9944917676722753,0.4116248018025536,0.0022735925425590446,"['SHC3', 'GNG4', 'PRKCD', 'PTK2B', 'CXCL14', 'HRAS']",0.9999313107513411,0,0,6
483,Common Pathways Underlying Drug Addiction WP2636,0.9955851751215534,0.1757546768707483,0.0007776439667812016,['ACTG1'],0.9999313107513411,0,0,1
484,Ciliopathies WP4803,0.9958698835157199,0.4737951356904127,0.001960881227168036,"['MAK', 'NME9', 'HYDIN', 'CCDC65', 'DNAAF4', 'CCNQ', 'WDR34', 'TRIM32', 'CCDC28B', 'GLI3']",0.9999313107513411,0,0,10
485,Ras signaling WP4223,0.9963036998952064,0.4537846153846154,0.0016804317281910468,"['HTR7', 'SHC3', 'GNG4', 'KIT', 'GAB1', 'PLD1', 'HRAS', 'FGFR2', 'ARF6']",0.9999313107513411,0,0,9
486,Mesodermal commitment pathway WP2857,0.9964020635980353,0.3669407601260929,0.0013226102814153991,"['PRKAR1A', 'SLC2A12', 'NOG', 'PBX3', 'RPL38']",0.9999313107513411,0,0,5
487,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.99754527471952,0.1581154336734694,0.0003886071094951697,['RPS6KA5'],0.9999313107513411,0,0,1
488,Prolactin Signaling Pathway WP2037,0.9976553416978502,0.2297847653303939,0.0005393993587307377,"['JUN', 'HRAS']",0.9999313107513411,0,0,2
489,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9977844795910027,0.37460329526234776,0.0008308619820067795,"['SLCO1C1', 'RPS6KA5', 'SHC3', 'SCD', 'HRAS', 'FOXO1']",0.9999313107513411,0,0,6
490,Wnt Signaling Pathway WP363,0.9981694916384504,0.1505557580174927,0.00027584612034046643,['ROR2'],0.9999313107513411,0,0,1
491,Interferon type I signaling pathways WP585,0.998419231322688,0.14703962980541055,0.00023261954844595157,['RPS6KA5'],0.9999313107513411,0,0,1
492,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.998419231322688,0.14703962980541055,0.00023261954844595157,['HRAS'],0.9999313107513411,0,0,1
493,Integrin-mediated Cell Adhesion WP185,0.9984538274909208,0.2667422157465868,0.0004127486536006612,"['SHC3', 'ITGA1', 'HRAS']",0.9999313107513411,0,0,3
494,IL-1 signaling pathway WP195,0.9991205748466927,0.13447134172818062,0.00011830951012257246,['JUN'],0.9999313107513411,0,0,1
495,Joubert Syndrome WP4656,0.9992850768035354,0.19729179961710275,0.00014109892747860415,"['KAT5', 'PDE6B']",0.9999313107513411,0,0,2
496,Genes related to primary cilium development (based on CRISPR) WP4536,0.9998700027628116,0.20769651804134562,2.7001728632120532e-05,"['CDK20', 'TULP3', 'WDR34']",0.9999313107513411,0,0,3
497,Ciliary landscape WP4352,0.9999313107513411,0.35442102173274914,2.434574984694101e-05,"['PSMD8', 'DOCK5', 'GID8', 'VPS4A', 'HTRA2', 'COPS7A', 'MYL6B', 'IQGAP2', 'WDR34', 'LSM4']",0.9999313107513411,0,0,10
